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ABSTRACT 
PHOTOBIOMODULATION IN INHERITED RETINAL DEGENERATION 
by 
Sandeep Gopalakrishnan 
The University of Wisconsin-Milwaukee, 2012 
Under the Supervision of Professor Janis T. Eells 
 
The retinal degenerative disease, retinitis pigmentosa (RP), is the most common cause of 
inherited blindness in the developed world and is caused by the progressive degeneration 
of rod photoreceptor cells preceding cone degeneration. Mitochondrial dysfunction and 
oxidative stress have been shown to play a significant role in the pathogenesis of RP and 
other retinal degenerative diseases. A growing body of evidence indicates that exposure 
of tissue to low energy photon irradiation in the far-red to near-infrared (NIR) range of 
the spectrum, (photobiomodulation or PBM) acts on mitochondria-mediated signaling 
pathways to attenuate oxidative stress and prevent cell death. These studies tested the 
hypothesis that PBM acts in the retina to promote mitochondrial integrity and function, 
prevent photoreceptor cell death and preserve retinal function in an established rodent 
model of retinitis pigmentosa, the P23H rhodopsin transgenic rat. Retinal function, 
structural integrity, surviving photoreceptors and the mitochondrial redox state were 
assessed using electroretinography, spectral domain optical coherence tomography, 
histomorphometry and cryofluorescence redox imaging.  PBM did not alter the structural 
and functional characteristics of retina in a non-dystrophic animal strongly supporting the 
safety of PBM.  Establishing the safety of PBM is essential to advance the therapy to 
clinical use. 830 nm PBM exerted a robust retinoprotective effect compared to 670 nm 
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PBM in the P23H transgenic rat model. 830 nm PBM during the critical period of 
photoreceptor degeneration in P23H transgenic rat profoundly attenuated retinal 
degeneration resulting in the preservation of retinal function; retinal morphology and 
retinal metabolic state in comparison to the sham-treated group. An in vivo longitudinal 
study corroborated the structural preservation observed in the cross-sectional study. 
These findings provide evidence supporting the therapeutic utility of PBM in the 
treatment of retinal degenerative disease.  They also further our understanding of the 
mechanism of action of PBM by showing that it improves mitochondrial function in the 
retinae of RP animals. By exploiting, the cells own mechanism of self-repair, PBM has 
the potential for translating into clinical practice as an innovative, non-invasive stand-
alone or adjunct therapy for the prevention and treatment of retinal diseases. 
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The vertebrate retina, is involved in generating visual perception in the visible range of 
the electromagnetic spectrum (400-760nm). Photoreceptors are key elements of the outer 
sensory retina that are activated by light. The first neuroanatomical studies revealing the 
complexity of the retinal structure were described in avian retinae by Santiago Ramon 
Cajal in 1888 (Piccolino, Strettoi et al. 1989). Light enters the vertebrate eye by the 
refraction at the corneal air interface. The lens focuses the light rays into the thin neural 
tissue-retina, which processes and extracts information from the inverted image. The 
vertebrate retina has a layered structure. The outermost layer contains the photoreceptors. 
There are two distinct types of photoreceptors, rods and cones, which can be 
differentiated morphologically (Figure 1). Cones (~5% of total photoreceptors) are small 
cone-shaped cells whereas rods (~95% of the total photoreceptors) are larger rod-shaped 
cells. Rod cells, containing rhodopsin pigment, are highly sensitive to low light intensity 
and have a low photon saturation threshold which enables night vision, whereas cone 
cells are for high resolution and color vision.  Photoreceptors have specialized structures 
called outer segments that are considered to be modified cilia and contain the enzymes 
and the proteins responsible for phototransduction. The outer segments discs are 
continuously replenished by the phagocytic function of retinal pigment epithelium (RPE).  
The RPE also reduces the backscattering of light that enters the eye. The photoreceptors 
have a distinct distribution in the retina.  In the peripheral retina the rod photoreceptors 
are abundant.  In the central retina-fovea, the cone density is at a maximum. The second 
layer of the retina has intervening neurons including bipolar cells, horizontal cells and 
amacrine cells and the third layer, the ganglion cell layer, is the final output layer to the 
visual cortex. 
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Figure 1 Both rod (A) and cone (B) photoreceptor consist of four distinct regions: 
an outer segment (OS) which contains stacks of  bilipid membranous discs 
embedded with photopigments which are responsible for photoabsorption and 
initiation of phototransduction cascade, an inner segment that contains 
biosynthetic and metabolic functions as well as optical functions which by  the 
phenomenon of total internal reflection confines the photons within the receptor 
(Hoang, Linsenmeier et al. 2002), a cilium connecting both the inner and the outer 
segments, and a synaptic terminal which signals to the inner retina by 
neurotransmitters. (Reproduced from Neuroscience. 2nd edition. Purves D, 
Augustine GJ, Fitzpatrick D, et al., editors. Sunderland (MA): Sinauer Associates; 
2001). 
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EVOLUTION OF PHOTORECEPTORS 
Historically it has been shown that the vertebrate retina evolved as two independent 
systems based on the nature and function of photoreceptors which enabled vision for both 
nocturnal and diurnal animals in the ancient visual landscape (Collin, Davies et al. 2009). 
The photoreceptor cell and the associated pigment cells enabled primitive life forms to 
move in the direction of light for phototaxis (Arendt 2003).  Additional cell types including 
lens cells, various supporting cells and muscle cells were added as the eye evolved and cell 
diversity is at a maximum in the vertebrate eye. Retinal tissue in vertebrates evolved 
during the development from the embryonic forebrain as an out-pocketing of the 
diencephalon, referred as the optic vesicle which further undergoes invagination to form 
the optic cup (Figure 2). The inner wall of the optic cup develops into retina and the outer 
wall develops into RPE. 
. 
 
 
 
 
 
 
 
Figure 2 Development of anatomical structures of eye from the optic vesicle.  
(Reproduced from Neuroscience. 2nd edition. Purves D, Augustine GJ, 
Fitzpatrick D, et al., editors. Sunderland (MA): Sinauer Associates; 2001). 
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ROD OUTER SEGMENT AND RHODOPSIN 
The shape of the outer segment of photoreceptors has been used to characterize its 
morphology and function. The photoreceptor has evolved unique structural, functional and 
biochemical specializations that enable the process of photoabsorption. The photoreceptor 
outer segment is a modified cilium that connects to the inner segment via a connecting 
cilium (Figure 1) which maintains the cytoplasmic connectivity. The outer segment has 
hundreds of stacked membranous disks surrounded by plasma membrane (Figure 3). The 
evagination and invagination of membranes form the base of the cilium results in the 
generation of outer segment. In rods the expanding membranes get detached and remain as 
free floating discs whereas in cones they remain attached to the outer segment membrane 
(Steinberg, Fisher et al. 1980).  
The outer segment of the photoreceptor is a dynamic structure and the length is maintained 
constant by shedding the distal end followed by its phagocytosis by the  retinal pigment 
epithelium, while nascent membrane biogenesis occurs at the base of the outer segment 
(Young and Bok 1969). The process of rod outer segment shedding and renewal is better 
understood than the cones and it follows a circadian pattern; there is increased shedding in 
presence of light and decreased shedding in dark (Goldman, Teirstein et al. 1980). 
Complete outer segment turnover period is approximately 10 days in normal Sprague-
Dawley rats but it alters when an animal is moved to a new intensity of light. The rod outer 
segment shortens during the first three days in a new intensity and later it lengthens, after 
which the outer segment length, as well as the rhodopsin content, is inversely related to the 
light intensity in the environment. This phenomenon is described as photostasis and it is 
believed to have evolved to adapt to variations in day-light intensity and duration 
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(Schremser and Williams 1995). The exact reason for outer segment renewal is unclear,  
but studies suggest that it confers plasticity to the rod photoreceptor and protects against 
damaging effects of constant light exposure (Penn, Tolman et al. 1992). 
 
 
 
 
 
 
 
 
Figure 3 The outer segment of the photoreceptor is a modified cilium containing 
numerous discs which has embedded light sensitive visual pigments. (Reproduced 
from Steinberg, Fisher et al. 1980) 
 
Rod photoreceptors are highly specialized neurons that have low spatial resolution, but 
high sensitivity and can detect a single photon. Conversely, cone photoreceptors are 
relatively insensitive to light with high spatial resolution and are therefore, responsible for 
visual acuity (Lamb, Baylor et al. 1979). The visual pigment Rhodopsin (Rho) is the 
predominant integral membrane protein (~ 50% of the disc surface area) in rods which 
occupies the membranes of the outer segment (Ridge and Palczewski 2007). Vertebral 
rhodopsin is a highly specialized G protein-coupled receptor (GPCR) which has seven 
transmembrane domains (H1 to H7) (Figure 4). Rho belongs to the class of A GPCRs 
within the superfamily and is made up of opsin apoprotein and a chromophore.  The opsin 
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molecule is synthesized in the inner segment by the Golgi apparatus and is transported to 
the outer segment at the area of cilium by fusion using G proteins (Papermaster, Schneider 
et al. 1985). The chromophore 11-cis-retinal is a vitamin A derivative (aldehyde of vitamin 
A1) which is bound covalently to the terminal amino group of L-lysine residue embedded 
in the membrane (Figure 5). 
 
 
 
 
 
 
 
 
 
 
Figure 4 Secondary structure of bovine Rho. The NH2-terminal tail and 
extracellular domain point toward the top and the COOH-terminal tail and 
cytoplasmic domain is toward the bottom. Letter codes indicate amino acid 
residues. The structure has 7 transmembrane α-helical segments (H1 to H7). Inset: 
structure of the chromophore -11-cis- retinal. (Reproduced from Menon, Han et 
al. 2001). 
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PHOTOTRANSDUCTION  
The sequence of events triggered within photoreceptor cells when a single photon is 
absorbed is referred as phototransduction and involves the following steps: activation of 
Rho, activation of G-protein, activation of effector phosphodiesterase (PDE), hydrolysis of 
cyclic guanosine monophosphate (cGMP) and closure of ion channels. Classic studies by 
Wald et.al. (1950), first showed that the primary interaction of light with the bound retinal 
chromophore is to drive the conversion of  11-cis-to-trans isomerization at the reaction 
speed of 10
-12
 sec (Wald, Durell et al. 1950). The absorption of photons in the visible range 
(absorption maximum, λmax~500nm) by 11-cis-retinal is due to the extended polyene 
structure of the Rho molecule (Rando 1996). Photoisomerisation makes the Rho molecule 
active (R*) which generates spectrally distinct intermediates of Rho (bathorhodopsin, 
lumirhodopsin, metarhodopsin I, and metarhodopsin II) that trigger an amplifying cascade 
Figure 5 A molecular ribbon diagram of inactive and active views of Rho from the 
43 Å crystal structure coordinate. Unlike other GPCRs Rho binds to 11-cis retinal 
(ligand) covalently both in inactive as well as photo activated state-11-cis dark form 
(yellow) to all-trans light (magenta). (Reproduced from Bourne and Meng 2000) 
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of biochemical events in the outer segment (Okada and Palczewski 2001). R* stimulates 
the G-protein transducin to its activated state (G*), which in turn activates the effector 
PDE to PDE*. Activated PDE* causes the hydrolysis of cyclic guanosine monophosphate 
(cGMP) to 5’-GMP. The decrease in intracellular cGMP leads to the closure of cGMP-
gated channels on the plasma membrane of the photoreceptor outer segment, thereby 
reducing the influx of sodium ions (Na
+
) through these channels, which results in 
membrane hyperpolarization. Hyperpolarization inhibits or decreases the release of 
glutamate at the synapse which is further relayed and processed as a neurochemical event 
by the second order retinal neurons and eventually to higher centers in brain.  Following 
excitation by a photon of light, the photoreceptor returns to its dark state by decay of R*.  
The protein  arrestin  blocks the ability of R* to convert transducin to G* which accelerates 
the decay of R* (Figure 6). The all-trans chromophore dissociates from opsin and is 
converted back to 11-cis-retinal and is transported out of the outer segment into the RPE 
where 11-cis-retinal combines with opsin to regenerate new Rho (McBee, Palczewski et al. 
2001). 
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Figure 6 Schematic representation of phototransduction cascade in rod 
photoreceptors. (Reproduced from Burns and Arshavsky 2005) 
 
In the dark, the photoreceptor is in a depolarized state (~ -40 mV) and a steady current 
known as dark current flows through the photoreceptor cell.  Recovery in dark is achieved 
by the reopening of the cGMP-gated channel by the binding of cGMP on the cytoplasmic 
side of the channel.  Although  Ca
2+
 and Mg
2+
 ions are involved, the inward current is 
mediated by Na
+
 influx and the outward current is carried largely by potassium ions (K
+
) 
flowing in the photoreceptor inner segment through K+ sensitive non-gated channels (Yau 
and Nakatani 1984). The photoreceptor is in a depolarized state at this stage and there is 
constant release of glutamate from the synaptic terminal. 
The direct pathway for visual signal processing is the vertical transduction pathway which 
transfers neurochemical signals from photoreceptor cells, to bipolar cells, to ganglion cells, 
to the optic nerve by synaptic connections. Lateral inputs from horizontal cells 
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(photoreceptor-bipolar synapse) and amacrine cells (bipolar-ganglion cell synapse) 
modulate this pathway in the retina and provide feedback connections (Figure 7). 
Glutamate is the major excitatory neurotransmitter released in the synapses. Once released 
from the presynaptic terminal of the photoreceptors, glutamate diffuses across the synaptic 
cleft and binds to the receptors (ionotropic and metabotropic glutamate receptors) located 
on the dendrites of the postsynaptic neurons (ON-center and OFF-center bipolar cells). 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 Schematic representation of information flow in the retina. Signals can 
pass both vertically and laterally. (Reproduced from Lagnado 2000) 
 
Neurons within the OFF-pathway (horizontal cells, OFF-bipolar cells, amacrine cells, and 
ganglion cells) express functional ionotropic glutamate receptors and glutamate binding 
onto these receptors opens cation channels, depolarizing the postsynaptic cell membrane. 
Glutamate binding onto metabotropic glutamate receptors (APB receptor, present in ON-
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bipolar cells) can have a variety of effects depending on the second messenger cascade to 
which the receptor is linked. Thus, postsynaptic responses to glutamate are determined by 
the distribution of receptors and transporters (to prevent glutamate induced toxicity) which 
in turn determine the signal conductance mechanisms underlying visual information 
processing within the ON and OFF-pathways. 
High metabolic demand of photoreceptors 
Phototransduction is a highly energy demanding process and the energy metabolism is a 
critical function that determines photoreceptor function and survival.  Like other neurons 
of the central nervous system, photoreceptors use ATP generated from glucose as their 
energy source and a decrease in the availability of glucose has been shown to accelerate 
photoreceptor death and subsequent loss of vision (Umino, Everhart et al. 2006). Vision is 
lost when blood supply to the eye is blocked for only 10 seconds (Linsenmeier 1990). 
Energy demand of photoreceptors resembles that of rapidly dividing cancer cells (Vander 
Heiden, Cantley et al. 2009). Oxygen microelectrode studies have shown that 
photoreceptors consume approximately three to four times more oxygen than any other cell 
in the central nervous system (Braun, Linsenmeier et al. 1995).  Photoreceptors metabolize 
glucose either anaerobically by glycolysis or aerobically by oxidative phosphorylation. 
Both rod dominated and cone dominated retinae use >80% of glucose for anaerobic 
glycolysis even in the presence of oxygen (Chertov, Holzhausen et al. 2011). Glucose 
enters the photoreceptors through the Glut-1 transporters present in the inner segment 
which is the site for high oxidative activity (Figure 8). Glucose is then phosphorylated by 
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hexokinase 2 and transported to the other parts of the photoreceptor cell (Gospe, Baker et 
al. 2010).  
Dense aggregates of mitochondria fill the apical region of photoreceptor inner segments 
and intraretinal oxygen profiles show a deep trough in the oxygen partial pressure at this 
site. A high concentration of oxidative enzymes indicates the unusually large amount of 
oxidative energy generated (Yu, Cringle et al. 2004) (Lowry, Roberts et al. 1956). Na
+
/K
+
 
ATPase activity, which is essential for the Na
+
 transport and the maintenance of the 
photoreceptor dark current is by far the most energy demanding process in 
phototransduction (Winkler 1981). Synthesis of high energy phosphate bonds for the rapid 
turnover of photoreceptor cGMP also requires an appreciable amount of energy (Ames, Li 
et al. 1992). 
Winkler investigated the ability of superfused rat retina to utilize substrates other than 
glucose for generating ATP and showed that pyruvate maintained the amplitude of Fast 
PIII (Intra retinal photoreceptor potential) and maintained the concentration of ATP in the 
absence of glucose (Winkler 1981). These results demonstrate that ATP generated by 
photoreceptor mitochondrial activity is capable of supporting cellular electrical activity 
when glycolytic production of ATP is blocked. Interestingly, when pyruvate was 
superfused at higher concentrations (20 mM) it did not completely substitute for glucose as 
a substrate in generating functional electrical responsiveness thus providing evidence that 
either glycolysis alone or Krebs cycle activity alone can maintain retinae at an optimal 
functioning level (Winkler 1981). 
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Figure 8 Metabolism in photoreceptors. The high metabolic demand in 
photoreceptors is met by adequate supply of glucose and oxygen by the choroidal 
vessels through the RPE cells. Oxidative phosphorylation in the mitochondria 
provides photoreceptors with adequate amounts of ATP for the high energy 
demanding phototransduction process. Increased ROS generated as a result of 
mitochondrial phosphorylation is removed by the antioxidant defense mechanisms 
involving enzymatic (superoxide dismutase, glutathione peroxidase, and catalase) 
and non-enzymatic (natural antioxidant glutathione) endogenous systems. The 
constant recycling of the photoreceptor OS and recycling of 11-trans-retinal in the 
RPE requires rapid macromolecular synthesis and active transport mechanism. 
Studies have shown that activated insulin receptors can up regulate the growth 
factor signaling that ends up regulating glycolysis through stimulation of mTOR 
phosphorylation. (Reproduced from Punzo, Xiong et al. 2012). 
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INHERITED RETINAL DEGENERATIONS  
 
Retinal degeneration is described as a class of human eye diseases characterized by the 
loss of photoreceptors leading to severe visual impairment and blindness. Inherited retinal 
degenerations (IRDs) are a genotypically and phenotypically diverse category of 
inherited diseases characterized by the loss or premature death of rod and cone 
photoreceptor cells leading to severe visual impairment and blindness in all ages and 
racial backgrounds. In most inherited retinal degenerations both the rod and cone 
photoreceptors die, but the degree to which the two cell types are affected differs with 
different disorders. Over the years, knowledge of gene mutations associated with IRDs 
has quickly grown and many disease related gene abnormalities have been mapped and 
identified. 148 genes and 186 loci have been identified with various IRDs 
(www.sph.uth.tmc.edu/RetNet/disease.htm;www.retina-international.com). Due to the 
heterogeneous nature of retinal degenerations many associated mutations have yet to be 
identified, emphasizing the need for additional research and the development of 
additional animal models. 
Retinitis Pigmentosa (RP) 
Retinitis Pigmentosa (RP) is a large genetically heterogeneous group of IRD and the most 
common cause of inherited blindness in the developed world. RP affects about one in 5000 
individuals worldwide (Hartong, Berson et al. 2006). The age at which the individuals 
show symptoms ranges from 30 to 60 years of age and even varies significantly between 
individuals in the same family. Molecular genetic techniques have revealed that 30-40% of 
RP cases are autosomal-dominant, 50-60% are autosomal-recessive and 5-15% are an X-
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linked trait. Individuals with an autosomal dominant trait generally retain vision longer 
than those with autosomal recessive or X-linked traits (Dryja, McGee et al. 1990) (Berger, 
Kloeckener-Gruissem et al. 2010). Non Mendelian inheritance patterns such as 
mitochondrial inheritance (maternal) are reported in a small proportion of cases (Kajiwara, 
Berson et al. 1994). The symptoms of RP are well characterized and affected individuals 
report impaired dark adaptation, night blindness and loss of peripheral vision. 
Characteristic clinical features in RP include thinning of pigment epithelium and retinal 
vasculature, optic disc pallor and classic pigmentary deposits referred as 'bone spicule' 
(Figure 9). There is an exponential loss of visual field area (2.6–13.5% loss annually) and 
electroretinogram amplitude (8.7–18.5%) in affected individuals. In 20-30% of the 
individuals affected by RP, the disease is associated with non-ocular diseases including 
Usher’s syndrome (type I and II), Bardet-Biedl syndrome and Refum’s disease (Hartong, 
Berson et al. 2006). Mutations in many rod photoreceptor specific genes including 
rhodopsin, arrestin and rod outer segment membrane proteins result in photoreceptor 
degeneration (Phelan and Bok 2000). In addition mutations within the RPE - CRALBP 
mutations and RDH5 mutations result in photoreceptor degeneration. 
 
 
 
 
 
Figure 9 Fundus image of a normal (left) vs. RP eye (right). (Reproduced from 
Farrar, Kenna et al. 2002) 
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Causal genes of Retinitis Pigmentosa 
Although the majority of RP cases are monogenic, the disease is characterized by its 
genetic heterogeneity. Researchers have identified mutations in 45 gene loci which cause 
RP (Berger, Kloeckener-Gruissem et al. 2010). The first gene abnormality in RP was 
reported in 1984 and was associated with gene for X-linked RP (Bhattacharya, Wright et 
al. 1984). In 1989, first autosomal RP (adRP) gene was localized to 3q. This mutation was 
a single-base substitution in codon 23 of rhodopsin gene (RHO) and it accounts for 12% of 
autosomal dominant RP in US (Dryja, McGee et al. 1990). This mutation within the 
rhodopsin gene at codon 23 in one allele causes a change from proline to histidine in the 
23
rd
 amino acid (P23H) of the rhodopsin molecule, which results in misfolding and 
mislocalization of the protein. This mutation results in an  autosomal dominant RP 
phenotype characterized by  night blindness (nyctalopia) during  adolescence resulting 
from  the initial loss of rod photoreceptors that carries the mutation followed by 
progressive loss of vision in adulthood resulting from  the secondary degeneration of 
cones,  loss of retinal vasculature and  optic disc pallor (Berson, Rosner et al. 1991). The 
second most observed adRP locus was on 6p and coded for mutations in retinal 
degeneration slow (RDS) gene encoding a vital component of OS disc membrane 
glycoprotein- Peripherin. Mutations in the peripherin/RDS gene are often associated with 
less progressive disorders and sometimes with atypical findings, including early macular 
involvement. 
The other common gene mutations seen in rod dominated retinal and vitreoretinal diseases 
including RP are classified in Figure 10. This includes ABCA4, USH2A, arrestin, MERTK, 
PRKCG, ROM-1, RPE 65, PDE6A  etc.,  highlights functional diversity and  investigators 
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still believe that about 40% of RP cases are due to genes that are yet undiscovered. In 
summary, the linkage studies done in early 1990s investigating mutations revealed the 
genetic complexity and heterogeneity associated with retinal degeneration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Classification of rod dominated retinal and vitreoretinal diseases 
including RP and casual genes. (Reproduced from Berger, Kloeckener-Gruissem 
et al. 2010). 
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Identified genes in RP normally encode for proteins that are essential for phototransduction 
cascade (RHO, PDE6A), vitamin A metabolism (ABCA4, PRE65), rod outer segment 
protein (ROM1), cell signaling (SEMA4A), cell-cell interaction (CDH23), RNA intron-
splicing factors (PRPF31), intracellular trafficking proteins (MYO7A), phagocytosis 
(MERTK) and proteins for  pH regulation (CA4) (Hartong, Berson et al. 2006). Loss of 
rod photoreceptors leading to altered retinal architecture (Figure 11 and Figure 12) is the 
outcome of abnormal physiology associated with mutated or absent gene products. 
Biochemical interaction between rods and cones and the mechanisms of secondary death of 
cones following rod mutations and the role of rod derived cone viability factors (RdCVF) 
in the degeneration process are still not clearly understood. 
 
 
 
 
 
 
 
 
 
 
Figure 11 Loss of retinal architecture in RP demonstrated by high resolution 
microscopy.(Reproduced from http://www.nei.nih.gov/eyeonnei/snapshot/archive/ 
0909.asp)  
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Figure 12 Schematic representation of photoreceptor loss in Retinitis Pigmentosa. 
Normal Retina (A), when rods start to die (B), extensive loss of rod photoreceptor 
as the disease progresses (C) and eventually retina will lose all the rod 
photoreceptors which results in reduced nutrient flow, which leads to the death of 
remaining photoreceptors and the loss of retinal architecture. (Reproduced from  
Punzo, Xiong et al. 2012). 
 
Therapeutic Approaches for the Treatment of RP 
There is presently no effective treatment for RP. A three year follow-up study on the 
natural course of RP has shown that patients with dominant, recessive, and X-linked RP 
taking vitamin A, Vitamin E or both  showed slower decline in electroretinography 
amplitudes compared to those not taking any supplements but the visual-field area and 
visual acuity was not significantly different between groups (Berson, Sandberg et al. 
1985).  A study investigating the role of docosahexaenoic acid (DHA), an omega-3 fatty 
acid, did not show a clear benefit (Hoffman, Locke et al. 2004).  Based on the findings in 
two animal models of RP it is postulated that reduction in the exposure to light can slow 
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down the rate of degeneration (Naash, Peachey et al. 1996).  Use of pharmacological 
agents including carbonic anhydrase inhibitors has been shown to decrease the secondary 
pathology associated with RP including edema of the macula (Fishman, Gilbert et al. 
1989). Valproic acid is an inhibitor of histone deacetylase and  is identified as a 
pharmacologic chaperone for treating RP and an active clinical trial is currently going on 
(Clemson, Tzekov et al. 2011). 
The recent advances in finding a cure for RP are based on gene specific therapies, 
transplantation of lost retinal tissue by tissue engineered grafts/encapsulated cell 
technologies, regeneration by pluripotent stem cells and the use of retinal prosthetic 
devices. Gene specific therapies are based on the type of mutation and substantial 
improvement towards clinical trials is made on experiments in animal model targeting 
RPE65 gene (Bennett, Tanabe et al. 1996). Gene silencing and interference RNA(RNAi)-
based gene therapy is being developed for dominantly inherited mutations (Cashman, 
Binkley et al. 2005). The potential use of transplanting RPE, photoreceptors or pluripotent 
stem cells is being widely investigated and studies have shown beneficial effects 
(Whiteley, Litchfield et al. 1996). Prosthetic devices that can electrically stimulate the 
optic nerve, optic nerve head and  the visual cortex and being tested in patients (Rizzo, 
Wyatt et al. 2003; Roessler, Laube et al. 2009). A clinical trial with second-generation 
electronic retinal implant-Argus II Retinal Stimulation System is ongoing and the implant 
is designed to take the place of degenerated photoreceptors in RP (www.clinicaltrials.gov).  
One difficulty in the treatment of RP is that many patients have already lost all or nearly all 
rod photoreceptors when they complain about compromised vision thus strategies should 
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be developed that can rescue the few remaining cone photoreceptors. Despite the advances 
mentioned above there is a clear need for a neuroprotective therapy that has the potential to 
attenuate photoreceptor cell loss during the course of the disease. Photobiomodulation 
holds the promise to be a retinoprotective non-invasive therapy for the prevention and 
treatment of retinal diseases.  
Animal Models of Retinitis Pigmentosa  
In most inherited retinal degenerations both the rod and cone photoreceptors die, but the 
degree to which the cell types are affected differs with different disorders and this 
heterogeneity is the biggest barrier and challenge in designing and developing 
therapeutics. Due to the heterogeneous nature of RP many associated mutations have yet 
to be identified which calls for additional  research and better animal models. Both 
transgenic mice (Pde6b
rd10
, rd11, Crb1
rd8
, nr, Tub
tub
, Rpe65
rd12
) and rat (P23H, S334ter) 
have been extensively used to understand the molecular mechanisms involved in 
inherited retinal degeneration. 
The first retinal degeneration animal model was the Pde6b
rd1 
mouse model 
 
discovered by 
Keeler in 1924, which demonstrated early-onset severe degeneration due to the lack of 
PDE 6 activity in the rod photoreceptors. This same phenotypic resemblance is found in 
patients suffering from adRP (Keeler 1924). The Pde6b
rd1 
mouse model  was  
successfully used in developing novel therapeutic strategies to rescue rod  degeneration 
by gene therapy. Cone degeneration has been prevented by introducing autologous bone 
marrow derived hematopoietic stem cells into the degenerating retinal vasculature 
(Takahashi, Miyoshi et al. 1999) (Otani, Dorrell et al. 2004). The Pde6brd10 (rd 10) mouse 
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model displays retinal degeneration with sclerotic retinal vessels by p28 and resembles a 
model of autosomal recessive mutation that maps to the chromosome 5. Pde6b
rd10 
is 
considered to be a better model than Pde6b
rd1  
for developing
 
pharmaceutical therapies 
and testing neuroprotective approaches for RP because of its later onset and mild 
degeneration phenotype. The shape and size of mouse eyes are challenging for surgical 
procedures and this led to the development of rhodopsin transgenic rat models which 
have larger eyes.  
The P23H transgenic rat is a model of autosomal dominant RP in which the rhodopsin 
transgene mimics a human form of RP common in North America (Dryja, McGee et al. 
1990). The transgene induces an autosomal dominant photoreceptor degeneration 
phenotype that renders the outer retina hyperoxic from early postnatal life (Wellard, Lee 
et al. 2005). As photoreceptors degenerate in P23H model, oxygen consumption 
decreases and oxygen tension increases in the outer retina. Choroid capillaries have been 
shown to auto regulate poorly to the changing hyperoxic environment and this is known 
to cause constriction of retinal vessels in  P23H transgenic rats, the RCS rat model and in 
the Abyssinian cat model of retinal degeneration (Yu, Cringle et al. 2004). Hyperoxia 
induced oxidative stress and reduced levels of antioxidant systems includin catalase 
render the retina particularly vulnerable to progressive degenerative processes. Increased 
oxidative stress activates fibroblast growth factor (FGF) and ciliary neurotrophic factor 
(CNTF) which results in a slower degeneration process that continues throughout life 
(Machida, Kondo et al. 2000). 
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Mechanisms of retinal degeneration have also been studied using induced degeneration 
models. In induced models physical (e.g., light) or chemical (e.g. nitrosourea) exposure to 
wild type or genetically engineered animals results in the induction of photoreceptor 
degeneration leading to different phenotypes of retinal degeneration from mild to severe. 
Induced models have the advantage of control over disease severity and onset. Many toxic 
agents (alkylating agent; N-Nitroso-N-methylurea) and strategies including iron overload 
and autoantibody treatments have been reported in the literature to induce the 
photoreceptor degeneration process in rodents (Yuge, Nambu et al. 1996), (Nambu, Yuge 
et al. 1997), (He, Poblenz et al. 2000). The most widely accepted induced rodent model is 
the light induced retinal degeneration model (LIRD) (Noell, Walker et al. 1966). The 
advantage of the induced model is that the severity of retinal damage can be adjusted 
according to the experimental needs. 
Mitochondrial dysfunction, oxidative stress and apoptosis in retinal degenerations 
Photoreceptors are the most metabolically active cells in the body. They have a dense 
concentration of mitochondria in their inner segments to provide ATP for the energy-
intensive processes of outer segment renewal and maintenance of the dark current 
(Bramall, Wright et al. 2010). Considerable evidence supports a key role for 
mitochondrial dysfunction and oxidative damage in the pathogenesis of photoreceptor 
cell death in RP and other retinal degenerative disorders (Campian, Qian et al. 2004).  
Human retinal dystrophies and degenerations and light-induced retinal degeneration have 
been associated with profound loss of retinal antioxidant systems and cytoprotective 
factors thus compromising the ability of retinal neurons and glia to protect against 
oxidative damage leading to apoptotic cell death (Carmody and Cotter 2000). 
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Mitochondrial dysfunction is also reported in a broad spectrum of pathologies including 
Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral 
sclerosis and many other neurodegenerative diseases 
Reactive oxygen species (ROS) are formed as the by-product of oxidative 
phosphorylation in the electron transport chain (ETC) of the mitochondria. There are 
important antioxidant systems including mitochondrial superoxide dismutase (MnSOD), 
glutathione (GSH) and thioredoxin to keep the concentrations of free radicals at a 
minimum and to prevent conversion to stronger oxidants. The inability of the antioxidant 
systems in the cell to quench the increased production of free radicals creates a 
biochemical imbalance referred as oxidative stress (Ceriello and Motz 2004). The 
production of reactive oxygen species and oxidative damage is increased under 
conditions of mitochondrial dysfunction (Shen, Yang et al. 2005). The ROS generated 
attack lipids, proteins and nucleic acids and disrupt their functions. The metabolic 
products generated by ROS interactions with these cellular components also disrupt 
major functions including energy metabolism, signal transduction, intracellular transport 
and various other functions. A key ROS molecule, superoxide (O2
–. 
), becomes highly 
reactive when combined with NO to form peroxynitrite (ONOO
-
)
 
and these potent 
oxidant molecules can oxidize chemical moieties including lipids, proteins and DNA and 
causing irreversible damage to them. These toxic reactions often result in cell death by 
apoptosis or necrosis (Butterfield, Reed et al. 2007). There is strong evidence regarding 
the link between oxidative stress and photoreceptor damage in various in vivo and in vitro 
experimental models (Vlachantoni, Bramall et al. 2011).  
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In many IRDs the defective gene is present in the rod photoreceptor, rod cell death 
precedes the cone cell death, and the mechanisms by which cone cells undergo apoptosis 
are still not clear. IRDs characterized by common rhodopsin mutations cause protein 
misfolding and retention in the endoplasmic reticulum (ER) which causes ER stress. ER 
stress activates sensor proteins that results in unfolded protein response (UPR) and 
activation of signaling pathways including ATF6 and PERK. These pathways reduce the 
translation and accelerate misfolding of protein. These abnormal proteins accumulate in 
the rods as opsin aggresomes. Similar proteinacious inclusions are reported in many 
forms of neurodegeneration,
 
including amyotrophic lateral sclerosis, Alzheimer's disease 
and Parkinson’s disease (Saliba, Munro et al. 2002). Oxidative stress is also generated in 
IRDs  due to reduced oxygen utilization by inactive mutant rod photoreceptors resulting 
in outer retinal hyperoxia which generates ROS and this is confirmed in Mertk
RCS/RCS
 rats, 
Tg. Rho
Pro23His
  (P23H) rats, and CEP290 mutant cats (Yu, Cringle et al. 2004) (Padnick-
Silver, Kang Derwent et al. 2006). ROS thus generated can cause post translational 
modification of thiol groups of enzymes and transcription factors leading to the activation 
of proapoptotic pathways thus decreasing photoreceptor survival (Janssen-Heininger, 
Mossman et al. 2008).  
Accumulation of mitochondrial ROS influences both retrograde (mitochondria to 
nucleus) and anterograde (nucleus to mitochondria) redox sensitive signaling pathways 
which are capable of initiating the process of apoptosis. Potential redox sensitive 
signaling components that cause photoreceptor cell death in IRDs are p53 (Ali, Reichel et 
al. 1998) and HDAC4 (Chen and Cepko 2009), but based on the nature of the 
photoreceptor stress many other pro and antiapoptotic factors are involved. Cell death by 
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apoptosis (both caspase dependent and caspase independent) is a unifying feature in 
various forms of inherited photoreceptor degenerations (Bramall, Wright et al. 2010). In 
several different rodent models of inherited retinal degenerations, aberrant photoreceptor 
apoptosis is demonstrated during the critical period of photoreceptor development in the 
retina.  
NEAR INFRARED (NIR) PHOTOBIOMODULATION 
 
Treatment of tissue with monochromatic photons in the far-red to near-infrared (NIR) 
region of the spectrum (λ=630-1000 nm), also known as photobiomodulation (PBM), 
improves mitochondrial function and promotes cell survival in cultured cells and animal 
models of disease  (Liang, Whelan et al. 2006) (Desmet, Paz et al. 2006).  PBM  has been 
used clinically to treat soft-tissue injuries and stimulate wound healing for more than 40 
years (Eells, Henry et al. 2003).  Photobiomodulation at wavelengths between 630-830 
nm at doses ranging from 3-6 J/cm
2
  has been shown to reverse harmful effects of neuro 
and developmental toxins, accelerate  wound healing in murine diabetic models of wound 
healing, improve recovery from ischemic reperfusion injury in the heart, prevent oral 
mucositis in pediatric bone marrow transplant patients and attenuate retinotoxic effects of 
methanol-derived formic acid in rodents (Wong-Riley, Liang et al. 2005), (Lim, Sanders 
et al. 2010), (Eells, Henry et al. 2003), (de Sousa, Santos et al. 2010).  
Recent studies have demonstrated that 670nm NIR photons delivered transcranially to the 
injury site in an in vivo model of partial optic nerve transection, a model of traumatic 
injury in the central nervous system, resulted in a decrease in secondary oxidative stress 
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in astrocytes, an increase in NG-2 immunopositive oligodendrocyte precursor cells 
(OPCs) and restored visual function (Fitzgerald, Bartlett et al. 2010). NIR photons have 
also been shown to induce neuroprotection and stimulate neural maturation in vitro in a 
rat pheochromocytoma cell line 12 (PC12) following oxidative stress and prevent 
rotenone-induced decreases in visual function in vivo by increasing cytochrome c oxidase 
and superoxide dismutase activity (Giuliani, Lorenzini et al. 2009) (Rojas, Lee et al. 
2008).  
Studies in rodent models of Parkinson’s disease and multiple sclerosis demonstrated that 
treatment with PBM reduced the severity of disease and decreased concentrations of 
cytotoxic and pro-apoptotic factors (Liang, Whelan et al. 2006). The prolonged effect of 
brief PBM treatment is consistent with the induction of signaling cascades that initiate 
gene expression, protein synthesis, and oxidative metabolism in damaged cells (Karu, 
Pyatibrat et al. 2004). In a model of toxin induced retinal dysfunction, microarray 
analysis showed that gene expression pathways involved in mitochondrial metabolism 
and cytoprotection were up regulated whereas pathways involved in cell death were down 
regulated. Studies to identify the genes and noncoding RNAs (ncRNAs) involved in the 
neuroprotective actions of NIR-PBM in light induced retinal degeneration model 
demonstrated 44 known genes and 6 ncRNAs whose expression was significantly 
increased in  light damage, was reduced below criterion when the retina was conditioned 
by PBM (Natoli, Zhu et al. 2010). Thus, existing data demonstrate the efficacy and 
therapeutic potential of NIR PBM.  
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The mechanism of near-infrared photobiomodulation 
Mechanistically, light in the spectrum of 630-1000 nm is hypothesized to interact with 
the mitochondrial enzyme cytochrome c oxidase, triggering signaling mechanisms 
(Figure 13) that result in improved mitochondrial energy metabolism, antioxidant 
production and cell survival (Liang, Whelan et al. 2006) (Desmet, Paz et al. 2006) 
(Wong-Riley, Liang et al. 2005). The cytoprotective action spectrum of NIR light 
corresponds with the cytochrome c oxidase absorption spectrum (Figure 14). 
Comparative spectral analysis for transition metals and their complexes and the 
biomolecules associated with cellular metabolism suggests that multinuclear enzyme 
containing Cu(II) complexes are involved in the cellular mechanisms of action of NIR 
(Karu 1999).  Comparing d-d transitions and charge transfer complexes of Cu with the 
action spectrum have revealed that the photoacceptor molecule is the terminal enzyme of 
the electron transport chain- cytochrome c oxidase. Mixed valence copper components of 
cytochrome c oxidase, CuA and CuB are believed to be the photoacceptor center of the 
molecule.  Cytochrome c oxidase plays a central role in the bioenergetics of the cell and 
it can also initiate secondary cell signaling pathways that activate transcription factors, 
alter gene transcription and enhance protein synthesis of antioxidants and other proteins 
creating a stable microenvironment for cell survival (Figure 13) (Karu 2010), (Desmet, 
Paz et al. 2006). 
Two pathways are widely accepted as the starting point of cellular signaling inside the 
cell following the interaction of NIR photons with the catalytic center of the cytochrome 
c oxidase. One of them is the photodissociation of NO from the binding sites on the heme 
iron and copper centers of cytochrome oxidase allowing oxygen to rebind to these sites 
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and restore normal mitochondrial respiration (Sarti, Giuffre et al. 2003) (Huang, Chen et 
al. 2009). Based on the presence or absence of the NO in the catalytic center, CuA reduced  
and CuB oxidized  are assumed to be associated with the charge-transfer channels and CuA 
oxidized and CuB reduced   of the chromophore are associated with the d-d transition of the 
catalytic center which is thought to regulate the downstream signaling effects involved 
(Karu 2010). The other pathway associated with the NIR interaction on mitochondria is 
the ATP extra synthesis. Excess generation of ATP in the cell is shown to significantly 
alter cellular metabolism in tetrodotoxin (TTX) treated primary cultured neurons (Wong-
Riley, Liang et al. 2005) (Figure 14).  TTX, a voltage dependant sodium channel blocker, 
decreases ATP demand, impedes neuronal impulses and down-regulates cytochrome c 
oxidase in primary cultured neurons. ATP thus acts not only as the energy currency of the 
cell but also as a critical molecule that can initiate downstream cell signaling. Specific 
receptor family that is directly activated by ATP – P2 family and the breakdown product 
adenosine-P1 family are identified (Burnstock 2009). These receptors and their subtypes 
(P2X, P2Y,  P2Y2, P2Y11) are shown to mediate the beneficial effects of NIR PBM and 
low level light therapy (Karu 2010). ATP when binds to P2Y receptors initiates a cascade 
of molecular evens in the cell, increasing the intracellular Ca
2+
 ions which can in turn act 
as a positive effector molecule for mitochondrial function. The postulated molecular 
interaction of NIR photons with cytochrome oxidase initiates a cascade of secondary cell 
signaling pathways that activates transcription factors, alters gene transcription and 
enhances protein synthesis of antioxidants and other proteins creating a stable 
microenvironment for cell survival (Figure 13) (Desmet, Paz et al. 2006) (Whelan, 
Buchmann et al. 2003). 
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Figure 13 Hypothesized cell signaling events following 
photoabsorption/photoexcitation of cytochrome c oxidase by NIR photons 
 
 
 
 
 
 
 
 
 
 
Figure 14 Activity of Neuronal Cytochrome Oxidase and Cellular ATP Correlates 
with Cytochrome Oxidase Action Spectrum. Reproduced from (Wong-Riley, 
Liang et al. 2005) 
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Mitochondrial retrograde signaling in NIR photobiomodulation 
The mitochondrion plays a central role in the cell by mediating diverse cellular functions 
and integrating signals between the nucleus and the organelle. Mitochondrial retrograde 
signaling is defined as the one way communication between mitochondria and the 
nucleus that regulates many cellular functions in both normal as well as diseased states 
(Butow and Avadhani 2004). The possibility of retrograde mitochondrial signaling was 
established with NIR photobiomodulation when studies showed an increase in DNA and 
RNA synthesis in cultured cells when irradiated with a range of   from 300 - 860nm, 
without a known chromophore in the nucleus that absorbs this range of . 
The above possibility was reconfirmed by many investigators using cell proliferation as 
the model system because proliferation increases the adhesion of cells to a matrix, as well 
as the DNA and RNA synthesis rate (Ryan and Hoogenraad 2007). Current knowledge 
about mitochondrial retrograde signaling in NIR photobiomodulation 
(Figure 15) demonstrates that it is mediated via mitochondrial membrane potential 
(ΔΨm), generation of ROS, altering the [Ca2+] dynamics in the cell, and influencing NO 
binding to cytochrome c oxidase (Karu 2008). cDNA microarray study on fibroblasts 
irradiated with 628 nm light revealed that 111 genes of 10 functional categories were 
upregulated of which seven were directly or indirectly associated with the cell 
proliferation. The three other genes upregulated were associated with transcription 
factors, inflammation and cytokines (Zhang, Song et al. 2003). Mitochondrial retrograde 
signaling in general is considered to be both a stress response and an adaptive response of 
the cell. Investigators largely agree that the action associated with near-IR radiation on 
mammalian cells and tissues is mostly adaptive in nature. Changes in the dose and 
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intensity of irradiation cause cyclic changes in the mitochondrial metabolic activity and 
the repose is characterized a bell shaped curve generalized in the Arndt-Schulz law. 
 
 
 
 
 
 
 
 
 
 
Figure 15 Putative mitochondrial retrograde signaling and other associated 
cellular events following photoabsorption by cytochrome c oxidase. (Reproduced 
from  Karu 2008). 
Experimental models using isolated mitochondria and whole cells irradiated with 
monochromatic radiation in the NIR range has been shown to affect ΔΨm and stimulate 
ATP synthesis. Studies using He-Ne laser irradiation of melanoma cells induced a sudden 
increase in ΔΨm and ATP concentration which was mediated via increased cytochrome c 
oxidase activity which in turn promoted the phosphorylation of Jun N-terminal kinase 
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(JNK) and activator protein-1 (AP-1) expression resulting in an increase in cell 
proliferation (Hu, Wang et al. 2007). Superoxide anion (O2
•−
) generated in mitochondria 
as a result of oxidative phosphorylation is the primary ROS molecule that is capable of 
altering the retrograde signaling pathway which is established by its relevance in the up 
regulation of matrix metalloproteinase-1 (MMP-1) (Schroeder, Pohl et al. 2007). ROS 
generation was monitored at the single cell level in real time along with changes in  ΔΨm, 
intracellular pH and [Ca
2+
] after irradiation with 647 nm NIR photons (Alexandratou, 
Yova et al. 2002).  Mitochondria are at the center of the crosstalk between Ca
2+, ΔΨm and 
ROS which is referred as the love–hate triangle. An increase in intracellular [Ca2+] is 
reported following irradiation with light of various wavelengths in mast cells, 
hepatocytes, isolated mitochondria and sperm cells (Karu 2008). This increase in 
intracellular [Ca
2+
] is part of mitochondrial retrograde signaling leading to activation of 
calcineurin, which in turn leads to the activation of transcription factor NF-κB (Butow 
and Avadhani 2004).  
Nitric oxide (NO
•
) is an important intramitochondrial signaling molecule and is generated 
in biological systems by nitric oxide synthases. NO directly binds to cytochrome c 
oxidase, modulates mitochondrial respiration (Cooper 2002) and is believed to induce 
mitochondrial retrograde signaling through altered ΔΨm. By inhibiting cytochrome c 
oxidase, NO not only interferes with the oxygen consuming ability of the cell but also 
alters the redox status of the respiratory chain and thus generates O2
•− 
(Brookes, Levonen 
et al. 2002). 
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Coherent light sources like lasers are limited in their ability to deliver far-red to near-
infrared light without producing thermal effects at the tissue interface. Moreover the 
narrow beam width makes it difficult to treat large areas using a laser. Non coherent 
sources like LED arrays were initially developed by NASA for experimental protocols in 
outer space. LED arrays can be tuned to generate light in the far-red to near-infrared 
range of the spectrum at optimal wavelengths and energy densities without producing any 
thermal effects. Light emitted by LED arrays at optimal wavelengths can penetrate skin 
and tissue to a depth of approximately 23 cm (Beauvoit, Kitai et al. 1994). Optimal 
wavelengths and energy densities necessary for therapeutic interventions have been 
characterized with NIR-LEDs. An energy density of 4 J/cm
2
 has been shown to be 
effective at stimulating biological processes. Further, NIR-LED light therapy has been 
deemed a nonsignificant risk by the FDA and has been approved for use in humans 
(Desmet, Paz et al. 2006). 
Mitochondrial dysfunction and oxidative stress is attributed to the pathogenesis of many 
retinal and optic nerve diseases including age-related macular degeneration, diabetic 
retinopathy and Leber’s hereditary optic neuropathy (Barron, Johnson et al. 2001). 
Oxidative stress plays a central role in laser burn injury, methanol induced retinal toxicity 
and many other retinal degenerative diseases (Seme, Summerfelt et al. 1999). Our 
understanding of the genetic and molecular mechanisms of retinal degenerations and 
retinal injury are incomplete and no efficient therapeutic strategy to prevent or manage 
the degenerations does exist. The long term goal should improve mitochondrial function 
and attenuate oxidative stress. Although the majority of investigators agree that 
cytochrome c oxidase is the major mediator for the beneficial effects of NIR PBM, the 
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role played by other cellular photoacceptors including cytochrome b, cytochrome c, 
catalase, nitric-oxide synthase and heme-containing proteins including neuroglobin 
require additional investigation. 
Pilot experiments conducted in collaboration with other investigators have demonstrated 
that NIR-PBM administered during the critical period (P10-25) of photoreceptor cell loss 
in an established rodent model of retinitis pigmentosa, the P23H-3 rat, increases retinal 
mitochondrial cytochrome oxidase activity and protects against apoptotic photoreceptor 
cell death. These findings demonstrate the promise of NIR-PBM as a potential non-
invasive therapy for the treatment of RP. These preliminary findings also call for a more 
thorough understanding of both the efficacy and mechanism of this therapeutic approach 
over the disease course. Studies proposed in this dissertation will test the therapeutic 
benefit of NIR PBM in the treatment of RP using this established and well-studied animal 
model of disease which are essential before NIR PBM can be translated to clinical trials 
for the treatment of RP and other retinal dystrophies.  
 
Rationale for the Comparison of 670nm vs. 830 nm light 
The optical window for effective tissue penetration of red to near infrared radiation 
allows researchers to postulate that possible specific biological effects of irradiation 
happens between λ=600 and λ=1000nm. Results from our lab demonstrated that the 
irradiation of retinae and optic nerve in vitro at λ=670 nm provided retinoprotection by 
increasing the survival and functional recovery of photoreceptors after an acute injury 
(Eells, Henry et al. 2003). Following our study many investigators demonstrated similar 
retinoprotective and neuroprotective effects with λ=670 nm in both in vivo animal models 
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and in vitro culture systems (Wong-Riley, Liang et al. 2005) (Rojas, Lee et al. 2008). 
Karu's laboratory, among others, has shown that the mitochondrion is the target organelle 
in photobiomodulation and comparative spectral analysis revealed that cytochrome 
oxidase acts as a photoacceptor molecule. In many in vitro models studied, two peaks in 
the action spectrum of cytochrome oxidase following photon irradiation were observed at 
670 nm and at 830 nm which prompted many researchers to focus on these two 
wavelengths to identify the cellular mechanisms involved in PBM (Karu 2008).  
There is a growing interest in the use and safety of low level light and laser for traumatic 
brain injury and neurodegenerative diseases (Zivin, Albers et al. 2009). A non-invasive 
transcranial application of 808-nm low level light therapy given 4 h following traumatic 
brain injury in a rodent model significantly decreased the lesion volume and preserved 
neurobehavioral function (Oron, Oron et al. 2012). Using similar light sources,  
investigators have shown an increase in cortical tissue ATP content following embolic 
strokes in rabbits (Lapchak and De Taboada 2010). A recently published study compared 
the efficacy of both λ=670 nm and λ=810-nm laser treatment in a traumatic brain injury 
model and showed that the neurologic severity score decreased by 21% in 670nm and 
32% in 810nm treated group when compared to that of the controls (Qiuhe Wu et. al, 
Proc. of SPIE Vol. 7552 755206-1).  
The above findings led us to conduct a pilot experiment using both 670 nm and 830 nm 
in rodent model of inherited retinal degeneration, P23H transgenic rat. The findings from 
this experiment demonstrated that 830 PBM treatments using LED monochromatic light 
source produced a more robust retinoprotective effect in the P23H rats treated from p10-
p25 when tested at p30 than the 670 nm treatment for the same intensity. Based on these 
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data we propose to examine the retinoprotective efficacy of both 670 nm and 830 nm 
LED treatment in P23H transgenic rat. 
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CHAPTER 2 
PRELIMINARY DATA AND SPECIFIC AIMS 
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PRELIMINARY DATA 
Mechanistic studies from our lab and other investigators have demonstrated that NIR 
photons interact with cytochrome oxidase, in mitochondria, triggering signaling 
mechanisms which result in increased efficiency of the electron transport chain (ETC), 
improved mitochondrial energy metabolism, up regulation of cytoprotective genes and 
improved cell survival in various in vitro and in vivo disease models (Eells, Wong-Riley 
et al. 2004). 
NIR PBM attenuates the loss of photoreceptors in the P23H rat during the ‘critical 
period’ of photoreceptor degeneration.  
Photoreceptor death in different P23H strains exhibits a specific pattern. Photoreceptor 
death is excessive during the early developmental stages (p10-p25) which is referred as 
the ‘critical period’ of photoreceptor degeneration in this dissertation (Figure 16). 
 
 
 
 
 
 
 
Figure 16 Comparison of degeneration rates of ONL in three different lines of 
P23H rhodopsin transgenic rat strains with control animal. (Reproduced and 
modified from http://www.ucsfeye.net/mlavailRDratmodels.shtml to highlight the 
‘critical period’). 
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Published work from our lab has shown that NIR PBM is retinoprotective against toxin-
induced damage, and recent studies have demonstrated that NIR PBM can attenuate 
photoreceptor cell death by 70% during the critical period of photoreceptor development 
(Figure 17) in the P23H-3 rat indicating that NIR PBM can alter the underlying pathology 
during the developmental stages of the retina (Eells, Wong-Riley et al. 2004). Our 
hypothesis is that oxidative stress is generated in P23H photoreceptors due to reduced 
oxygen utilization by inactive mutant rod photoreceptors resulting in outer retinal 
hyperoxia which generates ROS (Stone, Maslim et al. 1999; Yu, Cringle et al. 2004). 
 
 
 
 
 
 
 
 
 
Figure 17 Photoreceptor cell death by apoptosis is demonstrated in P23H retina by 
TUNEL+ cells and following NIR PBM there is a significant reduction (greater 
than 70%) in the number of TUNEL+ cells in the ONL. 
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ROS thus generated can cause posttranslational modification of thiol groups of enzymes 
and transcription factors, leading to the activation of proapoptotic pathways, thus 
affecting the photoreceptor survival particularly during early development. PBM acts to 
improve mitochondrial function and to increase antioxidant protection (Geller, Krowka et 
al. 2006). PBM-induced improvement of mitochondrial function would increase oxygen 
consumption in the P23H retina and reduce oxygen tension and thus reduce oxygen 
toxicity (Stone, Maslim et al. 1999). Secondly, it is thought that the PBM-induced 
increased production of cytoprotective factors and antioxidants would act in concert to 
protect the retina from apoptotic photoreceptor cell death. NIR-PBM administered during 
the critical period of photoreceptor development in the P23H-3 rat is neuroprotective.  
Photobiomodulation increases cytochrome oxidase concentrations in the P23H 
retina. 
 
In vitro studies in our laboratory and by other investigators have shown that NIR PBM 
improves photoreceptor oxidative metabolism by increasing mitochondrial cytochrome 
oxidase activity and upregulating key antioxidant protective enzymes, cofactors and 
neurotrophic factors in the retina, culminating in a significant attenuation of apoptotic 
photoreceptor cell death (Karu 1999; Eells, Wong-Riley et al. 2004; Ying, Liang et al. 
2008). As shown in Figure 18, NIR PBM significantly increased the concentration of 
cytochrome oxidase  in the retina of the P23H-3 rat. Density profiling of retinal layers for 
specific cytochrome oxidase immunolabeling shows increased labeling density in the 
inner segments of the photoreceptor cells, which is consistent with the higher 
mitochondrial density in the inner segments of photoreceptors. These findings are 
consistent with the in vitro observations and support our hypothesis that upregulation of 
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cytochrome oxidase activity is a critical component in the neuroprotective actions of NIR 
PBM. Our hypothesis is further supported by studies showing that increased cytochrome 
oxidase activity improves respiratory efficiency under conditions of oxidative stress, thus 
attenuating the production of reactive oxygen species (Campian, Qian et al. 2004). 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 A significant up regulation of cytochrome oxidase activity in the inner 
segments of photoreceptor cells following NIR PBM is demonstrated by density 
profiling (n = 6, p < 0. 001) 
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Photobiomodulation up-regulates cytoprotective enzymes in the P23H retina. 
Photoreceptor cell death by mitochondrial dysfunction, generation of reactive oxygen 
species and apoptosis are common in human retinal dystrophies and degenerations and 
light-induced retinal degeneration in animal models (Carmody and Cotter 2000). (Stone, 
Maslim et al. 1999). NIR-PBM not only increases cytochrome oxidase activity and 
oxidative capacity in the photoreceptors but also increases the concentrations of a critical 
neuroprotective factor in the retina, the mitochondrial form of superoxide dismutase, 
MnSOD (Figure 19). Overexpression of MnSOD in the retina has been shown to protect 
the retina against oxidative damage (Kanwar, Chan et al. 2007). Early AMD like 
characteristics are manifested in animal models with reduced retinal expression of 
MnSOD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 NIR PBM upregulates mitochondrial form of superoxide dismutase, 
MnSOD, in the inner segments, which can protect the degenerating retina from 
oxidative damage. 
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In summary, these preliminary data demonstrated that NIR-PBM treatment administered 
once per day for 5 days during the critical period of photoreceptor cell loss (p10-p25) in 
the P23H-3 rat increases retinal mitochondrial cytochrome oxidase activity, up regulates 
the production of antioxidant protective enzymes and attenuates apoptotic photoreceptor 
cell death.  
These preliminary data obtained in collaboration with Diana Kirk, Krisztina Valter, Ph.D, 
and Jonathan Stone, Ph.D. (Australian National University and Sydney University) 
support our hypothesis and set the stage for more detailed studies described below.  
 
SPECIFIC AIMS, RATIONALE AND DESIGN 
 
Specific Aim 1: To investigate the effect of NIR photobiomodulation in a non-
dystrophic (SD) animal. 
 
Specific Aim 2: To determine if NIR photobiomodulation can protect 
photoreceptors against damage induced by the P23H transgene and compare the 
efficacy of 670 nm vs. 830 nm PBM using three different treatment protocols. 
 
Three NIR-LED treatment paradigms will be tested.  
a) The first treatment protocol will determine if NIR PBM can rescue photoreceptor 
function during the critical period of photoreceptor development. In these studies, 
immature P23H rats will be treated once per day with 670 nm-LED or 830 nm-LED 
(4 J/cm
2
) during the critical period (p10-25). Retinal function (mixed and cone 
electroretinography responses), in vivo retinal imaging and histomorphometric 
analysis will be determined at p30.  
46 
 
 
b)  In the second treatment protocol, immature P23H rats will be treated once per day 
with 670 nm or 830 nm -LED (4 J/cm
2
) from the onset of the critical period of 
photoreceptor cell death to young adulthood (p10-p40). The efficacy of NIR PBM 
will be assessed at p45 by measurement of retinal function, in vivo retinal imaging 
and photoreceptor cell loss as above. These studies will determine if a longer 
treatment protocol will improve photoreceptor protection and retinal function 
compared with a limited treatment protocol.  
c)  In the third treatment protocol, we will determine if photobiomodulation can rescue 
remaining photoreceptors and preserve retinal function in young adult rats in which 
the majority of rods have degenerated. For these studies young adult P23H rats (P20) 
will be treated once per day with 670 or 830 nm nm-LED (4 J/cm
2
) from p20 to p40 
and we will examine the efficacy of photobiomodulation at p50 as described above.  
Rationale and design for Specific aim 2: The P23H rhodopsin transgenic rat is a model 
of autosomal dominant retinitis pigmentosa in which photoreceptor degeneration 
especially the rod degeneration begins as early as p10. The ONL thickness decreases 
from approximately 46µm from p10 to 22µm by p25 which is considered as the critical 
period of photoreceptor degeneration in this model (Yu, Cringle et al. 2004). Rod 
degeneration is nearly complete by p60. The first two experimental designs will 
investigate the therapeutic potential of NIR-PBM during the critical period (p10-p25) and 
from critical period to young adulthood (p10-p40). The third design will investigate the 
potential of NIR-PBM to rescue remaining photoreceptors and preserve retinal function 
after the majority of rods have degenerated. 
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Specific Aim 3:  To investigate the cellular changes underlying the protection 
provided by NIR photobiomodulation.  
 
These studies will test the hypothesis that NIR-PBM will stimulate photoreceptor 
bioenergetics by up regulating retinal cytochrome oxidase expression and will also up 
regulate antioxidant protective pathways and neuroprotective factor production.  
The experiments described in specific aim 2 will characterize the effects of NIR-PBM on 
RP. The functional biochemical and molecular studies will provide information on the 
mechanism(s) by which NIR-PBM protects retinal function. These experiments are 
fundamental in determining the potential of NIR-PBM as a therapeutic approach in the 
prevention and treatment of retinal dystrophies and retinal degenerative disease. The 
results of this research may provide the essential information required to initiate an 
investigation into the clinical use of NIR-PBM as an innovative and noninvasive 
therapeutic approach.  
Rationale and design for specific aim 3: Oxidative stress and mitochondrial dysfunction 
play vital roles in the pathogenesis of photoreceptor cell death in retinal degeneration. 
These studies will test the hypothesis that NIR-PBM will improve mitochondrial function 
and attenuate oxidative stress in the P23H rat.   
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CHAPTER 3 
MATERIALS AND METHODS 
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ANIMAL MODEL 
All animal experiments have been approved by the Institutional Animal Care and Use 
Committee (IACUC) and were conducted in accordance with the ARVO (The 
Association for Research in Vision and Ophthalmology) statement for the use of animals 
in ophthalmic and vision research and with the National Institutes of Health regulations. 
Heterozygous P23H transgenic rats, the offspring of P23H homozygotes and Sprague-
Dawley (SD) albino rats (Harlan Sprague Dawley, Madison, WI) were used as the model 
of retinal degeneration. The original P23H homozygotes were obtained from Retinal 
Degeneration Rat Model Resource at University of California, San Francisco.  
This model was selected for the following reasons:  
(1) It is a widely studied model of retinal dystrophy, allowing us to integrate and 
compare our findings with those of other investigators (Walsh, van Driel et al. 2004) 
(Yu, Cringle et al. 2004) (Machida, Kondo et al. 2000).  
(2) Several neuroprotective strategies have been investigated in the P23H rat, facilitating 
a comparison with the efficacy of PBM (Leonard, Petrin et al. 2007) (LaVail, 
Yasumura et al. 2000) 
(3) The time course of photoreceptor degeneration in the P23H rat is relatively short, 
enabling us to evaluate the efficacy of photobiomodulation within a few months and 
to modify treatment protocols depending on our findings.  
Housing conditions and light management 
All animals were bred and housed in an American Association for Accreditation of 
Laboratory Animal Care (AAALAC) approved animal facility at the University of 
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Wisconsin-Milwaukee. Animals were supplied food and water ad libitum and maintained 
in a temperature and humidity-controlled environment under dim cyclic light, 12-hour 
light/12-hour dark cycle, with an average illuminance of 5 to 10 lux inside the cage. 
NIR LIGHT EMITTING DIODE ARRAY AND TREATMENT 
PROTOCOL 
 
A monolithic array of custom fabricated (λ=670nm and λ=830nm) Light Emitting Diodes 
(LED) engineered to eliminate heat (Hybrid GaAlAs, Quantum Devices, Inc., Barneveld, 
WI) and designed to emit diffused monochromatic light at specific wavelength of photon 
energy were used to deliver light at a desired energy density. The LEDs are shielded by a 
glass barrier and are unlensed, allowing for even dispersion of light over a 180° viewing 
angle (Figure 20). This allows each LED chip to act as a point source, providing a high 
degree of illumination uniformity. The hybrid lamp housing contains the ceramic 
substrates on which LED arrays are assembled, acting as a heat sink. A fan is mounted on 
the opposite side of the light source to keep the monolithic system running cool. The 
LED arrays are factory calibrated for proper LED wavelength and intensity before use. 
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Figure 20 LED arrays used for delivering NIR photons. WARP 75 LED Unit 
(Left);   λ = 670 ± 20 nm; Surface Energy: 60mW/cm
2
 ; Fluence ~5.4J /cm
2 
.  
SpectraLife LED Hybrid Lamp (Right);   λ=830nm ± 10 nm; Surface Energy: 
50mW/ cm
2 
; 
 
Fluence ~4.5 J/cm
2 
Immature and young adult P23H-1 transgenic rats were hand-held by the investigator or 
placed in a plexiglass restraint device and the WARP 75 or SpectraLife LED Hybrid 
Lamp were positioned directly over the animal’s head at a distance of 2 cm exposing both 
eyes (Figure 21). Sham-treated SD rats were handled in the same way, except that they 
were not exposed to the LED array. These treatment protocols have been used with both 
immature and adult rodents and are well tolerated by the animals. Treatment consisted of 
irradiation at 670 nm for 90 sec at a power intensity of 50mW/cm
2
, resulting in an energy 
density of 4.5 joules/cm
2
 at the surface of the cornea or irradiation at 830 nm for 180 sec 
at a power intensity of 25mW/cm
2
, resulting in an energy density of 4.5 joules/cm
2
 at the 
surface of the cornea. These stimulation parameters have been previously demonstrated 
to stimulate cell survival and cytochrome oxidase activity in cultured neurons, to promote 
wound healing clinically and in experimental animal models  to promote the survival and 
functional recovery of the retina and optic nerve in vivo after acute injury by a 
mitochondrial toxin and to exhibit neuroprotective actions in the retinae of P23H rats 
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(Liang, Whelan et al. 2006) (Ying, Liang et al. 2008) (Desmet, Paz et al. 2006) (Whelan, 
Buchmann et al. 2003) (Eells, Henry et al. 2003).  
 
 
 
 
 
 
 
 
Figure 21 Exposure of animals to NIR photons. Animals were habituated to the 
restraint apparatus and handling from p5. Monochromatic LED source is placed 
directly over the animal’s head at a distance of 2 cm exposing both eyes. 
 
ASSESMENT OF STATUS OF RETINA 
To evaluate the therapeutic efficacy of 670 nm and 830 nm PBM, the status of the retinae 
was assessed by measuring well established indices of photoreceptor function, 
photoreceptor morphology and by a new measurement of retinal oxidative metabolism   
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Photoreceptor function will be assessed by  
Full-Field Flash Electroretinography 
Animal preparation 
The function of the retina was monitored using full-field flash electroretinography 
(ERG), which measures the electrical impulses emitted by the retina in response to 
flashes of light. Animals were dark adapted for at least 2 hours prior to recording and 
were prepared under red dim light. Animals were anesthetized with an intraperitoneal 
injection of xylazine- ketamine hydrochloride cocktail (5 mg/kg and 100 mg/kg 
respectively). Pupils were dilated with 0.1% atropine and mild topical anesthesia was 
applied on the eyes.  Animals were placed on a heating pad to maintain the body 
temperature at 37°C during the entire recording time. Full-field ERGs were obtained 
using Handheld Multi-species ElectroRetinoGraph (HMsERG) Instrument (Retvet Corp, 
MO). 
Photostimulator  
 The Mini-Ganzfeld half-sphere bowl is 76 mm in diameter, and has a 55 mm circular 
aperture (Figure 23). This is illuminated with white LEDs, which have a rated color 
temperature of around 7000
0
 K and flash intensities ranging from 10 mcd.s/m
2
 to 30 
cd.s/m
2
. Flash intensity is set by a combination of flash time (from 5 microseconds to 5 
milliseconds) and LED peak current. The white light flash intensity in the Ganzfeld dome 
is protocol dependent. The individual tests set the flash intensity from 10 mcd.s/m
2
 to 
25000  cd.s/m
2 
and the flash duration runs from 0.005 to 5 msec. Any required 
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background illumination can also be set.  The photostimulator is intended to be used 
close to the animal’s eye (between 1 and 2cm). 
Placement of electrodes and ERG recording 
A nylon coated gold thread electrode was placed on the corneal surface, overlaid with 1% 
methylcellulose and a small drop of methylcellulose was placed into the concave side of 
the contact lens before it was placed over the thread electrode. The corneal contact lens 
will be adjusted so that it was centered on the retina. Stainless steel needle ground 
electrode was inserted on top of the head (midline). Stainless steel needle reference 
electrodes were inserted subcutaneously on either side of the base of the ear. Needle 
electrodes were secured with surgical tape (Figure 22).  Signals obtained from the corneal 
surface were amplified, digitized and averaged using ERG view 2.5 software (Retvet 
Corp, MO). This software allows for low pass filtering of  the final ERG test waveforms 
before they are graphed on the unit. This filter can be used to remove environmental and 
unit generated noise from the observed ERG. A custom designed Faraday cage was 
employed block 60 cycle electrical noise. The amplitudes and latencies of the a-waves 
(photoreceptor responses,) and b-waves (bipolar cell and Muller cell responses) were fit 
to a computational model to determine transduction parameters for photoreceptor 
responses(Figure 24 & 25). 
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Figure 22 Animals were dark-adapted, anesthetized, pupils dilated and placed on 
a thermoregulated heating pad at 37°C during recordings. 
 
 
 
 
 
 
 
Figure 23 Full-field ERGs were obtained in a Mini-Ganzfeld half-sphere bowl. 
Flash intensities are generated with white LEDs and duration of the each flash is 
test dependent. 
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Figure 24 A normal biphasic ERG waveform showing a-wave and b-wave 
amplitude and corresponding implicit times. Reproduced from 
www.webvision.med.utah.edu. The a-wave reflects  the physiological activity in 
the photoreceptors of the outer retina and the b-wave corresponds to the electrical 
responses from the inner retinal layers including the ON bipolar cells and the 
Muller cells (Miller and Dowling 1970). 
 
 
 
 
 
Figure 25 Comparison of a-wave and b-wave amplitude obtained from a normal 
subject (left) and from a patient with RP. Reproduced from 
www.webvision.med.utah.edu  
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Due to the high number of rods in the rodent retina compared to cones, the ERG response 
following a white flash of light is predominantly the rod photoreceptor response.  The 
flash intensity, number of flashes and its rate and the exposure time can be manipulated 
so that the rod and cone photoreceptor function can be isolated. Two well established 
protocols are used in this dissertation.  
Scotopic intensity series protocol 
This protocol gives the best estimate of the functional status of the retina using increasing 
flash intensities over a fixed time period (Table 1). The resulting scotopic intensity 
response curves were plotted and compared between treated and sham control animals. 
 
Table 1 Protocol for scotopic intensity series electroretinography (Reproduced 
and modified from HMsERG user manual). 
 
Action Flash intensity 
Log             mcd.s/m2 
Number 
of flashes 
Avg’d 
Interval 
seconds 
Action 
time 
Seconds 
Elapsed 
Time 
Seconds 
Test 1 -1.5 100 4 10 40 40 
Delay     60 100 
Test 2 -1 300 4 10 40 140 
Delay     60 200 
Test 3 -0.5 1000 4 10 40 240 
Delay     60 300 
Test 4 0 3000 4 10 40 340 
Delay     60 400 
Test 5 0.5 10000 1   400 
Delay     60 460 
Test 6 ~1.0 25000 1   460 
Delay       
 Total Time Elapsed in  
Minutes 
                                                           7.7 
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International Society for Clinical Electrophysiology of Vision (ISCEV) protocol 
To tease out individual and combination of photoreceptor response, ISCEV 
recommended protocol is used (Table  2). Varying the flash intensity, duration and rate of 
stimulation after dark adaptation and background adaptation (with 30000 mcd.s/m
2
 
intensity for 10 minutes) will help to isolate rod response as well as cone photoreceptor 
response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 ISCEV protocol for electroretinography. The animals are dark adapted for 
20 minutes before the procedure. The ISCEV protocol includes 7 standardized 
individual tests as recommended by the ISCEV (Reproduced and modified from 
HMsERG user manual). 
ERG test 
Session 
Flash intensity 
Log             
mcd.s/m2 
Number 
of 
flashes 
Avg’d 
Interval 
seconds 
Action 
time 
Seconds 
Elapsed 
Time 
Seconds 
Dark 
Adaptation 
ISCEV recommends 20 Minutes 
Rods -2.5 10 10 2 18 18 
Delay   4 2 2 20 
Std.Rods & 
Cones 
0 3000  10 30 50 
Delay   4  30 80 
Hi.Int.Rods 
& Cones 
0.5 10000  20 60 140 
BG 
adaptation 
1 30000   600 740 
Cones with 
BG 
0 3000 32 0.5 15.5 755.5 
Delay w/BG     2 757.5 
Hi Cones 
with BG 
0.5 10000 32 0.5 15.5 771 
Delay with 
BG 
    2 773 
Std.Flicker 
w/BG 
0 3000 128 0.032 4.192 777.2 
Delay with 
BG 
    2 779.2 
Hi.Int. 
Flicker 
w/BG 
0.5 10000 128 0.032 4.192 783.4 
 Total time elapsed in Minutes                                                      13.06 
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Retinal Morphology will be assessed by  
Spectral Domain Optical Coherence Tomography (SD-OCT) imaging 
Optical coherence tomography is a non-invasive optical imaging technique that uses low 
coherence interferometry to create high resolution, cross-sectional, two and three 
dimensional tomograms of biological tissue in vivo (Drexler, Morgner et al. 2001). OCT 
is extensively used in ophthalmology to understand retinal and corneal morphology to 
help early diagnosis and detection of ocular pathologies, when treatment is most 
promising. Specific advantages of OCT include excellent depth (axial) and lateral 
resolution, which allows finer anatomical details of the retina to be observed (Figure 26).  
 
 
 
 
 
 
 
Figure 26 Set up of an OCT system for retinal imaging. The light source is 
typically a broad band source and the light (λ~ 800nm) is split into half by a beam 
splitter and sent to a reference arm and the sample arm. The backscattered light is 
reflected back from the sample arm and reference arm combines forming an 
interference pattern. This spectrum is detected via a spectrometer placed as the 
detector and an algorithm is used to reconstruct an A –scan which represents the 
anatomical features of retina. Multiple A-scans are used to generate B-scan and 
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multiple B-scans are used to generate 3D volume scans. (Reproduced and 
modified from Frohman, Fujimoto et al. 2008). 
Animal Imaging Mount and Rodent Alignment System 
Before the animal is anesthetized for imaging, the Animal Imaging Mount (AIM) and 
Rodent Alignment System (RAS) are aligned with the long axis of animal cassette with 
laser. Once the long axis of the laser and the cassette are along the same z-axis, an aiming 
tip is placed at the end of the bore and adjustments are made to achieve the “Magic 
Point” for aiming. The “Magic Point” is referred to as the intersection of 3 axes which are 
Cassette center line, Optical axis of the imaging probe and the Cassette swivel axis 
(Figure 27). 
 
 
 
 
 
 
 
 
Figure 27 Aligning the AIM-RAS to achieve the “Magic Point” for aiming (Reproduced 
and modified from Bioptigen’s Guide to Small Animal Imaging: Optimizing Image 
Quality presentation by Joseph Vance). 
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Animal preparation 
Animals were anesthetized by an intraperitoneal injection with a ketamine and xylazine 
mixture (50:5 mg/kg body weight) and the pupils are dialated with 1% atropine sulphate 
ophthalmic solution. After one minute hydrate the cornea with sterile Systane Ultra 
Lubricant Eye Drops (Polyethylene Glycol 400, 0.4% and Propylene Glycol 0.3%; Alcon 
Labs). Systane Ultra offers the right balance of viscosity and optical properties, and the 
corneal surface is hydrated every 2 minutes during the entire period of anesthesia to 
prevent dryness and opacities arising from exposure keratopathy. Lubricant is wicked 
away before acquiring an image to have high image quality. Both eyes were imaged in a 
single session by mounting the animal with a bite bar on a custom made six-axis rodent 
alignment system. The bite bar is laterally and ventrally adjusted to align the animal eye 
with the “Magic Point” for aiming (Figure 28). 
 
 
 
 
 
 
 
 
Figure 28 Animal Imaging Mount and Rodent Alignment System with bite bar. 
The bite bar helps to reproduce alignment of the rodent eye and suppress motion 
artifacts from breathing. 
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The fundus imaging camera in the animal imaging mount provided initial alignment for 
the light source during the real time aiming. The Optic Nerve Head (ONH) will be used 
as a landmark and the alignment of the OCT optics with the retina usually is done with a 
‘Fast Fundus’ scan (200x100x1.6x1.6x1x1). This scanning allows the user to get real-
time feedback on the location from volume intensity projection (VIP) as user adjusts the 
cassette. After positioning the ONH, aiming mode was used to adjust the image 
brightness and contrast. Two linear scans at1000x80x1 (0 degree and 90 degree) and 2 
volume scans at 750x250x1x1 (0 degree and 90 degree) per eye were captured and saved 
using the Bioptigen's InVivoVue
TM
 software. The linear scans were exported from the 
OCT machine and read into ImageJ (http://www.rsb.info.nih.gov/ij/) for processing.  A 
rigid body registration is performed using the ImageJ plug-in “StackReg”. The frames 
that have motion artifacts were removed subjectively before averaging to prevent 
surrounding frames from causing distortion. Averaging also removes large amount of 
speckle noise contained in individual OCT scans. The averaged scans from P23H and SD 
animals were used for segmentation of retinal layers for total retinal thickness (Figure 29) 
using algorithm generated in MATLAB (Mathworks, Natick, Massachusetts, USA). 
 
 
 
Figure 29 Representative image (line scans 1000x80x1samplings) centered on the 
ONH, showing the segmentation lines for automated segmentation for Total 
Retinal Thickness. 100 pixels (px) are removed at the ONH manually to account 
for variable thickness in this region. 
100px 
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Automated segmentation generates retinal thickness over the entire B-scan and a 100 
pixel correction was used in the final average thickness to account for variable thickness 
in this region. The difference in reflectivity of retinal layers was explored in generating 
longitudinal reflectivity profiles (LRP) (Figure 30) for individual layers from the 
averaged scans using ImageJ at fixed locations from the 100 pixel area as demonstrated 
in Figure 31. 
 
 
 
 
Figure 30 Longitudinal Reflectivity Profile (LRP) and the corresponding individual 
retinal layers (Nerve Fiber Layer; NFL & Ganglion Cell Layer; GCL, Outer Plexiform 
Layer; OPL, Outer Nuclear Layer; ONL, Inner Segment/Outer Segment; IS/OS, Retinal 
Pigment Epithelium; RPE and Choroid) 
 
 
 
 
 
Figure 31 Method used to generate spider plots for ONL thickness from averaged OCT 
scans. 
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Quantitative Morphometric Analysis: Measurement of ONL thickness 
ONL thickness was measured as previously described (Komeima, Rogers et al. 2007) . At 
the defined time points, animals were euthanized with an overdose of sodium 
pentobarbital (>60 mg/kg, intraperitoneal). One eye from each animal was prepared for 
histological and immunohistochemical evaluation. The retina dissected from the other 
eye was collected in Trizol for molecular analysis. The eyes for histology and 
immunohistochemistry were marked at the superior position (in the corneal limbus) using 
a surgical cautery and eyes were  removed and embedded  either in  paraffin, plastic or  
optimal cutting temperature compound (Tissue-Tek OCT Compound ,Sakura Finetek 
USA , Inc.) depending upon the parameters investigated. The Ten-micrometer sections 
will be cut perpendicular to the 12:00 meridian through the optic nerve. The sections 
were stained with Harris hematoxylin and eosin (Fisher Scientific, Pittsburgh, PA), 
Toluidine blue and was placed in mounting medium and examined with a Olympus 
Axioskop microscope (40x objective). The images were digitalized and analyzed with 
ImageJ  by outlining the ONL and then measuring the ONL thickness at three locations 
(100 µm, 200 µm and 300 µm) on the superior pole of  the optic nerve and three locations 
(100 µm, 200 µm and 300 µm) on the inferior pole of  the optic nerve as described (Usui, 
Komeima et al. 2009).  
Photoreceptor protection was assessed by 
Measurement of Surviving photoreceptors: The number of surviving photoreceptors 
was quantified by the thickness of the ONL and by counting the rows of nuclei in 
Toluidine blue stained resin sections, and a comparison analysis was made with the 
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SDOCT images at the same location. The number of cells observed in the outer nuclear 
layer (ONL), inner nuclear layer (INL) and ganglion cell layer (GCL) were counted and 
recorded separately for each 1mm distance from the ONH and a spider graph was plotted.  
 
Experimental Design and Methodology for Aim 2: To investigate the effect of PBM 
on mitochondrial function in the P23H retina. 
Retinal metabolic state was assessed by Cryo Optical Imaging 
Fluorescence imaging provides specific information on tissue using intrinsic fluorophores 
or exogenous tagged proteins. Since some of the molecules in the cell act as intrinsic 
fluorophores and are able to fluoresce when excited with the appropriate wavelength, a 
growing field of fluorescence microscopy techniques relies on autofluorescent 
fluorophores. Fluorescence-based techniques are widely used in biomedical applications 
as diagnostic tools for early detection of various diseases such as cancers or heart disease 
(Ranji, Jaggard et al. 2006). Optical fluorescence techniques have the potential to 
diagnose tissue metabolic states in intact organs. These techniques are widely used in 
biomedical applications and have been shown to have a high sensitivity and specificity 
for discriminating between diseased and non-diseased tissue (Richards-Kortum, Mitchell 
et al. 1994) (Wagnieres, Star et al. 1998). 
Oxidative phosphorylation in the mitochondria provides photoreceptors with adequate 
amounts of ATP for the high energy demanding phototransduction process, and 
mitochondrial metabolic coenzymes Nicotinamide Adenine Dinucleotide (NADH), and 
Flavin Adenine Dinocleotide (FADH2) are the primary electron carriers in oxidative 
phosphorylation. NADH and FAD (the oxidized form of FADH2) are autofluorescent and 
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can be monitored without exogenous labels through the use of optical techniques. These 
coenzymes are beneficial in that NADH is primarily fluorescent in its reduced 
biochemical state, whereas FAD is only fluorescent in its oxidized form. Therefore, by 
imaging these two coenzymes, we can probe the oxidative state of the metabolism in 
tissue. The fluorescent signals of these intrinsic fluorophores have been used as indicators 
of tissue metabolism in injuries due to hypoxia, ischemia, and cell death (Ranji, 
Kanemoto et al. 2006). The normalized ratio of these fluorophores, (NADH/FAD), called 
the NADH redox ratio (NADH RR), acts as a novel marker of the mitochondrial redox 
and metabolic state of tissue ex vivo and in vivo (Maleki, Sepehr et al. 2012). 
 
Sample Preparation: Freezing and embedding 
The rats were sacrificed, and their eyes were harvested and frozen rapidly for low 
temperature cryoimaging. The eyes were embedded in a black mounting medium as 
shown in Figure 32 and scanned by the cryoimager in 500 slices each 10 µm apart 
through the whole eye. 
 
 
 
 
 
 
 
Figure 32 (a) frozen eye  and b) embedding frozen eye in customized mounting 
medium. 
 
a b 
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Calibration 
A calibration method was designed to compensate for day-to-day variation of light 
intensity and non-uniformity of the illumination pattern. At the beginning of each 
experiment and before slicing the tissue, a uniform fluorescent flat plate was placed in the 
same position as tissue and imaged in all channels to acquire the illumination pattern. 
Since the fluorescence of the standard is in both the NADH and FAD channels, it also 
accounts for day-to-day light intensity and uniformity changes in all channels.  All the 
images in each channel were then normalized by dividing each image to the flat plate 
image, captured in the same channel. 
Cryoimager 
Figure 33  shows the schematic for the 3D cryoimager used in this study. The cryoimager 
is an automated image acquisition and analysis system consisting of software and 
hardware designed to acquire fluorescence images of tissue sections. A motor-driven 
microtome sequentially sections frozen tissue at the desired slice thickness while filtered 
light from a mercury arc lamp excites up to five distinct fluorophores in the exposed 
surface of the tissue block. The excitation light source is a 200W mercury arc lamp 
filtered at the excitation wavelengths of NADH and FAD, 336 nm and 470 nm, 
respectively. The emission wavelengths are 520 nm and 450 nm for FAD and NADH, 
respectively. At each slice, a CCD camera records fluorescence images of the tissue 
block in pixel dimensions of 10 µm × 10 µm to be later analyzed for fluorophore 
distribution. The microtome is housed in a freezer unit that maintains the sample at -80°C 
during sample slicing and image acquisition. The resolution in the z direction of 
68 
 
 
microtome slices can be as small as 5 um. For this study, we used a resolution of 10 um 
in the z direction, which resulted in ~ 400 z-slices per eye. 
 
 
 
 
 
 
 
Figure 33 Schematic representation of a Cryoimager. This device sequentially 
slices the tissue, imaging the surface between each successive slice, in as many as 
5 channels. The images are then displayed and saved to a computer, where they 
can be processed to create a 3-D rendering of the tissue. 
 
Data analysis 
FAD and NADH autofluorescence images (containing 250 slices per eye) from each 
group of eyes were processed using Matlab. The composite images were created using all 
the image slices for each eye, for both NADH and FAD signals. The ratio of NADH and 
FAD, known as the NADH redox ratio (Sepehr, Staniszewski et al. 2012), was calculated 
voxel by voxel, using Matlab, according to equation (1).     
        Redox Ratio = RR = NADH / FAD        (1) 
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The 2D representation of each eye was then calculated using the maximum intensities in 
the z axis of the NADH redox 3D volume (max projection). In the maximum projection 
method, first a full 3D volume of images was obtained, including RR, and then the 
maximum projection on the volumetric data was performed and the histograms were 
plotted for this maximum projection. The maximum projection is used since the entirety 
of the anatomy has a significant contribution in this representation. A histogram of the 
max projection of RR values in each group was created, and the mean (or first moment) 
of this histogram was calculated according to Eq. (2). 
                                         
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Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in 
x and y is 10μm and 10μm. The previously mentioned histograms were calculated for 
quantitative comparison between normal and diseased groups.  
Statistical Analysis 
Sample size for the experiment will be determined by power analysis. The data obtained 
from the study will be analyzed using SPSS. All values will be expressed as means ± 
SEM. A mixed model ANOVA (Greenhouse-Geisser correction was performed whenever 
the assumption of sphericity was violated), MANOVA, 1-way ANOVA (Kruskal-Wallis 
test) and Student's t-test performed, as appropriate. Statistical analysis was performed 
using SPSS 19.0 (SPSS Inc, Chicago, IL) and GraphPad Prism 4.0 (GraphPad, La Jolla, 
CA USA). The level of significance for all statistical tests was set at 0.05 
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CHAPTER 4 
EFFECT OF NIR PHOTOBIOMODULATION IN NON -
DYSTROPHIC ANIMAL MODEL 
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Many studies with PBM have shown that in the absence of pathology, there is no 
physiological action of the light.  Moreover, our previous studies on methanol and light 
induced toxicity models of retinal degeneration demonstrated the lack of any significant 
effect of NIR treatment on normal, healthy and non-challenged retinal physiology. Natoli 
et al. (2010) demonstrated by wide-scale gene analysis that NIR treatment resulted in the 
up regulation of many noncoding RNAs (ncRNA) (Natoli, Zhu et al. 2010). The inability 
of ncRNAs to translate to a functional protein may explain the cellular effects of NIR 
PBM in a non-dystrophic retina. Follow up studies are needed to characterize the exact 
role of these ncRNAs in the mammalian retina. Albarracin et al. suggested a possible 
hypothesis that the up regulated ncRNAs in the above animal models following NIR 
PBM may not have any significant function in the healthy retinal cellular environment 
but may be acting as a pre-conditioning event in the retina leading to altered regulation of 
potentially damaging genes in the presence of stress stimuli, as seen in induced or 
inherited retinal degenerations (Albarracin, Eells et al. 2011).  
Studies were performed to characterize the role of NIR-PBM during the early phase of 
photoreceptor development in non-dystrophic SD animal at both 830 nm and 670 nm. 
 
830 nm photobiomodulation does not alter retinal function in non-dystrophic SD 
rats.  
Figure 34 and Figure 35 summarizes the average a-wave and b-wave amplitudes 
measured by dark-adapted full-field flash ERG using the scotopic intensity series 
protocol. In agreement with the previously published data from our lab and other 
colleagues 830 nm PBM in a non-challenged retina does not alter retinal function. 
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The main effect of mean ERG amplitudes between non-dystrophic SD and 830nm treated 
non-dystrophic SD rats for a-wave (F(1,14) = .627, p = .442; Figure 34 ) and for b-wave 
(F(1,14) = .122, p = .733 ; Figure 35 ). 
 
 
 
 
 
 
 
 
 
 
Figure 34 shows the comparison of mean a-wave amplitude between SD normal 
control (■; n=8) and 830nm treated SD normal control (▲; n=8) groups. The a-
wave represents the functional electrical activity recorded from the photoreceptors 
and reflects the general health of the photoreceptor layer of the retina. The main 
effect between groups were not statistically significant (F(1,14) = .627, p = .442) 
between groups at various flash intensities. Error bars: SEM. 
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Figure 35 shows the comparison of mean b-wave amplitude between SD normal 
control (■; n=8) and 830nm treated SD normal control (▲; n=8) groups. The b- 
wave represents the functional electrical activity post synaptic to photoreceptors 
and reflects the health of the inner layers of the retina. The main effect between 
groups were not statistically significant (F(1,14) = .122, p = .733) between groups at 
various flash intensities. Error bars: SEM. 
 
Figure 36 and figure 37 summarize the mean  a- wave and b- wave implicit times for the 
above scotopic intensity series protocol.  
The main effect of mean ERG implicit times between non-dystrophic SD and 830nm 
treated non-dystrophic SD rats for a-wave (F(1,14) = 1.14 , p = .302;  Figure 36 ) and for b-
wave (F(1,14) = 4 .12, p = .062 ; Figure 37). 
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Figure 36 shows the  mean a-wave implicit time comparing SD normal control (■; 
n=8) and 830nm treated SD normal control (▲; n=8) groups. The a-wave implicit 
time represent s the time from flash onset to the trough of the a-wave. There was 
no significant difference (F(1,14) = 1.14 , p = .302) between groups at various flash 
intensities. Error bars: SEM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37 shows the mean b-wave implicit time comparing SD normal control (■; 
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n=8) and 830nm treated SD normal control (▲; n=8) groups. The b-wave implicit 
time represents the time from flash onset to the peak of the b-wave. There was no 
significant difference (F(1,14) = 4 .12, p = .062)  between groups at various flash 
intensities.  Error bars: SEM 
 
670 nm photobiomodulation does not alter the retinal function and retinal 
morphology in non-dystrophic SD animal. 
Figure 38  and figure 39  show  the average a-wave and b-wave amplitudes assessed by 
dark-adapted full-field flash ERG using scotopic intensity series protocol comparing non-
dystrophic SD and 670nm light treated non-dystrophic SD rats.  Similar to our findings 
with 830 nm PBM, 670 nm PBM did not alter retinal function or retinal morphology in 
the non-dystrophic retina.  
The main effect of mean ERG amplitudes between non-dystrophic SD and 670 nm 
treated non-dystrophic SD rats for a-wave (F(1,10) = .039, p = .848; Figure 38 ) and for b-
wave (F(1,12) = .147, p = .708 ; Figure 39). 
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Figure 38 shows the comparison of mean a-wave amplitude between SD normal 
control (■; n=6) and 670 nm treated SD normal control (▲; n=8) groups. The a-
wave represents the functional electrical activity recorded from the photoreceptors 
and reflects the general health of the photoreceptor layer of the retina. The main 
effect between groups were not statistically significant (F(1,10) = .039, p = .848) 
between groups at various flash intensities. Error bars: SEM 
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Figure 39 shows the comparison of mean b-wave amplitude between SD normal 
control (■; n=8) and 670 nm treated SD normal control (▲; n=6) groups. The b- 
wave represents the functional electrical activity post synaptic to photoreceptors 
and reflects the health of the inner layers of the retina. The main effect between 
groups were not statistically significant (F(1,12) = .147, p = .708) between groups at 
various flash intensities. Error bars: SEM. 
 
 
Figure 40  and Figure 41  summarize the mean  a- wave and b- wave implicit times for 
the above scotopic intensity series protocol .  
The main effect of mean ERG implicit times between non-dystrophic SD and 670 nm 
light treated non-dystrophic SD rats for a-wave (F(1,14) = .103. , p = .752;  Figure 40) and 
for b-wave (F(1,14) = 2.31, p = .151 ; Figure 41) 
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Figure 40 shows the  mean a-wave implicit tine comparing SD normal control (■; 
n=8) and 670 nm treated SD normal control (▲; n=8) groups. The a-wave 
implicit time represent s the time from flash onset to the trough of the a-wave. 
The main effect between groups were not statistically significant (F(1,14) = .103. , p 
= .752) at various flash intensities. Error bars: SEM. 
 
 
 
 
 
 
 
 
 
 
Figure 41 shows the mean b-wave implicit time comparing SD normal control (■; 
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n=8) and 670 nm treated SD normal control (▲; n=8) groups. The b-wave 
implicit time represents the time from flash onset to the peak of the b-wave. There 
was no significant difference (F(1,14) = 2.31, p = .151)  between groups at various 
flash intensities.  Error bars: SEM 
 
Total retinal thickness was quantified in non-dystrophic SD and 670 nm light treated non-
dystrophic SD rats using SD-OCT and the mean total retinal thickness (Figure 42) was 
not significantly different between the groups (SD: 174.2 ± 2.3 µm, n=4 vs. SD-670: 
181.0 ± 2.4 µm, p<.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AVG_P10-P25-SD3_670nm_OD_L_2_0_OOOOOO2 
AVG_P10-P25-SD1_OD_L_2_0_OOOOOO2 
SD 
SD-670nm 
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Figure 42 shows the average total retinal thickness (upper panel) generated from 
SD-OCT linear scans (n=4) between non-dystrophic SD animals and 670 nm 
treated SD animals. Lower panel shows the representative linear scans at the same 
location on the retina (ONH used as the landmark) comparing non-dystrophic SD 
animal and 670 nm treated SD animal and there was no significant difference in 
the retinal morphology or structural integrity of retina following 670 nm NIR-
PBM. Error bars: SEM     
 
 
In summary 830 nm and 670 nm photobiomodulation did not alter the functional 
response or the structural integrity of retina in a non-dystrophic control animal.  These 
findings are important with respect to both animal and human safety considerations. This 
is a crucial piece of evidence for a comprehensive FDA approval for the use of NIR-LED 
devices in control populations in clinical trials for the treatment of retinal degenerative 
diseases. 
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CHAPTER 5 
MITOCHONDRIAL REDOX IMAGING  
 
 
 
 
 
 
 
 
 
 
 
 
[This Chapter is submitted to be considered for publication in the Journal of Biomedical 
Optics and the authors assign(s) to Society of Photo-Optical Instrumentation Engineers 
(SPIE) copyright ownership in the work presented in this Chapter, effective if and when 
the Paper is accepted for publication by SPIE and to the extent transferable under 
applicable national law] 
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Introduction 
 Irreversible loss of rod photoreceptors is the outcome of abnormal physiology 
associated with mutated or absent gene products and leads to blindness in many retinal 
degenerative disorders, including retinitis pigmentosa (RP). RP is a large genetically 
heterogeneous group of inherited retinal degeneration characterized by progressive and 
neurodegenerative photoreceptor apoptosis with subsequent degeneration of the cone 
photoreceptors and the retinal pigment epithelium (RPE) cells (Besch, Jagle et al. 2003; 
Sancho-Pelluz, Arango-Gonzalez et al. 2008). RP is the leading cause of inherited retinal 
degeneration-associated blindness in the developed world (Hartong, Berson et al. 2006). 
To date 52 genes are known to be associated with all forms of RP inheritance (Neveling, 
Collin et al. 2012). Although the majority of RP cases are monogenic, the disease is 
characterized by its genetic heterogeneity and approximately 10% of the RP cases are due 
to defects in rhodopsin (RHO) gene (Dryja, McGee et al. 1990). The Pro23His (P23H) 
rhodopsin mutation underlies the most common form of human autosomal dominant 
retinitis pigmentosa (adRP). The symptoms of RP are well characterized and a prominent 
early clinical feature of RP manifests as night blindness with peripheral visual field loss 
as a result of the death of rod photoreceptor cells (Shigenaga, Hagen et al. 1994; Wallace 
2005; Bramall, Wright et al. 2010). 
 Photoreceptors are the most metabolically active cells in the body. They contain a 
dense concentration of mitochondria in their inner segments that provides the ATP for the 
energy-intensive processes of outer segment renewal and maintenance of the dark current 
(Bramall, Wright et al. 2010). The high metabolic demand in photoreceptors for 
phototransduction processes is met by mitochondrial oxidative phosphorylation 
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(OXPHOS). The retina is also adequately supplied with glucose and oxygen by the 
choroidal vessels through the RPE cells. ATP is generated as a result of the synchronized 
activity of tricarboxylic acid (TCA) cycle and the multi enzyme complex-electron 
transport chain (ETC). The coenzymes, nicotine adenine dinucleotide (Karunadharma, 
Nordgaard et al.) (Karunadharma, Nordgaard et al.) and flavin adenine dinucleotide 
(FADH2) are electron carriers in the ETC.  Between 0.4–4.0% of all oxygen consumed in 
OXPHOS is transformed to superoxide (O2
−
) radicals (Shigenaga, Hagen et al. 1994) 
which are converted to H2O2 by Mn superoxide dismutase (Wallace 2005) and finally to 
molecular H2O by glutathione peroxidase (GPX) or peroxiredoxin III (PRX III) (Green, 
Brand et al. 2004). However, the inability of the antioxidant systems (superoxide 
dismutase, glutathione and thioredoxin systems) in the mitochondria to quench the 
increased production of reactive oxygen species (Ranji, Kanemoto et al.) (Ranji, 
Kanemoto et al.) creates a biochemical imbalance known as oxidative stress (OS), 
resulting in oxidative damage to the mitochondrial proteins, lipids and DNA. This 
oxidative damage initiates a cascade of events resulting in mitochondrial dysfunction and 
cell death (Shigenaga, Hagen et al. 1994; Wallace 2005; Vlachantoni, Bramall et al. 
2011). Considerable evidence supports a key role for mitochondrial dysfunction and 
oxidative damage in the pathogenesis of progressive photoreceptor cell death by 
apoptosis in RP both in vitro (Sanvicens, Gomez-Vicente et al. 2004; Sanz, Johnson et al. 
2007) and in vivo (Donovan, Carmody et al. 2001; Yamada, Yamada et al. 2001; Sanz, 
Johnson et al. 2007). Mitochondrial dysfunction and OS have also been documented in 
other retinal degenerative disorders including glaucoma, age-related macular 
degeneration (AMD) and diabetic retinopathy, as well as, numerous neurodegenerative 
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disorders including Parkinson’s disease and Alzheimer’s disease (Lin and Beal 2006; 
Pieczenik and Neustadt 2007; Kong, Van Bergen et al. 2009; Karunadharma, Nordgaard 
et al. 2010). 
 Optical fluorescence techniques have been shown to posses a high sensitivity and 
specificity for discriminating between diseased and non-diseased tissue. Fluorescence 
imaging provides specific information on tissue intrinsic fluorophores as a diagnostic tool 
for early detection of different diseases (Ramanujam, Richards-Kortum et al. 2001; Ranji, 
Kanemoto et al. 2006; Ranji, Matsubara et al. 2009; Maleki, Sepehr et al. 2012; Sepehr, 
Staniszewski et al. 2012). Here we used optical fluorescence imaging to evaluate the 
redox state of the P23H transgenic and the Sprague-Dawley (SD) normal retina. 
Although a link between OS and photoreceptor degeneration has been proposed, a direct 
analysis of the redox state within the mitochondrial compartment of the rodent eye has 
not been performed. We hypothesized that there would be a significant difference in the 
optical redox ratio of dystrophic retina of the P23H rat compared to that of the non-
dystrophic normal rat. We tested this hypothesis using a 3-D optical cryofluorescence 
imaging technique.  
 Mitochondrial metabolic coenzymes NADH and FADH2 are two of the primary 
electron donors and acceptors in OXPHOS, respectively. NADH and FAD (the oxidized 
form of FADH2) are autofluorescent and can be monitored without exogenous labels 
through the use of optical techniques. NADH is primarily fluorescent in its reduced 
biochemical state, whereas FAD is only fluorescent in its oxidized form. Therefore, by 
imaging these two coenzymes, we can probe the mitochondrial redox state of the tissue. 
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Although this ratio is not a direct measure of the concentrations of these fluorophores, the 
fluorescence intensity measured is a relative measure of their concentrations (Maleki, 
Sepehr et al. 2012). The fluorescent signals of these intrinsic fluorophores have been used 
as indicators of tissue metabolism in injuries due to hypoxia (Ranji, Kanemoto et al. 
2006; Ranji, Matsubara et al. 2009; Maleki, Sepehr et al. 2012; Sepehr, Staniszewski et 
al. 2012), ischemia (Ranji, Kanemoto et al. 2006; Ranji, Matsubara et al. 2009), and 
diabetes (Maleki, Sepehr et al. 2012). Our studies have demonstrated that the ratio of 
these fluorophores, (NADH/FAD), called the NADH redox ratio (NADH RR), acts as a 
quantitative marker of the mitochondrial redox and metabolic state of tissue ex vivo 
(Ranji, Jaggard et al. 2006) and in vivo (Matsubara, Ranji et al. 2010).  
 We evaluated the mitochondrial redox state quantitatively in the in situ retina 
using a 3-D fluorescent optical imaging instrument called the cryoimager to detect the 
oxidative state of the retina in P23H transgenic (diseased) eyes as well as SD normal eyes 
Materials and Methods 
 
Animal preparation: 
 All animal experiments were approved by the Institutional Animal Care and Use 
Committee (IACUC) and were conducted in accordance with the ARVO (The 
Association for Research in Vision and Ophthalmology) statement for the use of animals 
in ophthalmic and vision research and with the National Institutes of Health regulations. 
All animals were housed and bred in an American Association for Accreditation of 
Laboratory Animal Care (AAALAC) approved animal facility at the University of 
Wisconsin-Milwaukee.  
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 Albino SD normal and heterozygous P23H-1 transgenic rats, the offspring of 
P23H-1 homozygotes (Retinal Degeneration Rat Model Resource, UCSF) and SD normal 
albino rats (Harlan Laboratories, Madison) were fed ad libitum and maintained in a 
temperature and humidity-controlled environment under dim cyclic light, 12-hour 
light/12-hour dark cycle, with an average illuminance of  5 to 10 lux inside the cage. 
Once animals reached P30, they were divided into two groups. The heterozygous P23H-1 
rats were the model of retinal degeneration and SD normal albino rats were used as non-
dystrophic controls. 
Electroretinogram Recording: 
 The function of the retina was monitored using full-field flash electroretinography 
(ERG), which measures the electrical impulses emitted by the retina in response to 
flashes of light. Animals were dark adapted for 2 hours prior to recording and were 
prepared under red dim light. Animals were anesthetized with a xylazine/ketamine 
cocktail (100 mg/kg and 5 mg/kg respectively, ip). Pupils were dilated with 0.1% 
atropine and mild topical anesthesia (proparacaine 0.5%)  was applied to the eyes. 
Animals were placed on a heating pad to maintain the body temperature at 37°C during 
the entire recording period. A nylon coated gold thread electrode was placed on the 
corneal surface, overlaid with 1% methylcellulose and a small drop of methylcellulose 
was placed into the concave side of the contact lens before it was placed over the thread 
electrode. The corneal contact lens was adjusted so that it was centered on the retina. A 
stainless steel needle ground electrode was inserted on top of the head (midline). 
Stainless steel needle reference electrodes were inserted subcutaneously on either side of 
the base of the ear. Needle electrodes were secured with surgical tape. Signals obtained 
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from the corneal surface were amplified, digitized and averaged using ERG view 2.5 
software (Retvet Corp, MO). This software allows for low pass filtering of  the final ERG 
test waveforms before they are graphed on the unit. This filter can be used to remove 
environmental and unit generated noise from the observed ERG. A custom designed 
Faraday cage was employed to block 60 cycle electrical noise. The amplitudes and 
latencies of the a-waves (photoreceptor responses) and b-waves (bipolar cell and Muller 
cell responses) were stored in a Compact Flash storage card and fit to a computational 
model to determine transduction parameters for photoreceptor responses. 
 
Freezing and embedding: 
 SD normal and P23H-1 transgenic rats were euthanized at postnatal day 30. The 
eyes were enucleated and frozen rapidly on dry-ice for low temperature cryoimaging. For 
fluorescence imaging, the tissue was embedded in a customized black mounting medium 
(that is not fluorescent in the excitation wavelengths) and placed on a chilled aluminum 
plate to keep the tissue in place for freezing and slicing. The embedding process starts 
with freezing the base medium, embedding the tissue and fixing its position by adding 
more black medium around the tissue. After embedding, the tissue was stored in an 
ultralow freezer for subsequent imaging. The plate was then installed in the cryoimager 
where the surface of the black medium is parallel to a microtome. Figure 32 shows a 
frozen eye sample and an eye sample embedded in the customized black mounting 
medium. 
 
Imaging calibration: 
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 A calibration method was designed to compensate for day-to-day variation of 
light intensity and non-uniformity of the illumination pattern. At the beginning of each 
experiment and before slicing the tissue, a uniform fluorescent flat plate was placed in the 
same position as tissue and imaged in NADH and FAD channels to acquire the 
illumination pattern. Since the fluorescence of the standard is in both the NADH and 
FAD channels, it also accounts for day-to-day light intensity and uniformity changes in 
all channels. All the images in each channel were then normalized by dividing each 
image to the flat plate image, captured in the same channel. 
 
Cryoimager: 
 The cryoimager, which is shown in Figure 33 is an automated image acquisition 
and analysis system consisting of software and hardware designed to acquire 
fluorescence images of tissue sections. A motor-driven microtome sequentially sections 
frozen tissue at the desired slice thickness whereas filtered light from a mercury arc lamp 
excites up to five fluorophores in the exposed surface of the tissue block. The excitation 
light source is a 200W white light filtered at the excitation and emission wavelengths of 
NADH and FAD. At each slice, a CCD camera records fluorescence image of the tissue 
block in pixel dimensions of 10 µm × 10 µm to be later analyzed for fluorophore 
distribution. The microtome is housed in a freezer unit that maintains the sample at -20°C 
during sample slicing and image acquisition. The resolution in the z direction of 
microtome slices can be as small as 5 um. For this study, we used a resolution of 10 um 
in the z direction, which resulted in ~ 500 z-slices per eye. (Bernard, Ewen et al. 2000; 
Sepehr, Staniszewski et al. 2012) 
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Image processing: 
 NADH and FAD autofluorescence images (containing 500 slices per eye) from 
each group of eyes were processed using MATLAB. Composite images were created 
using all the image slices for each eye, for both NADH and FAD signals. The ratio of 
NADH and FAD, was calculated voxel by voxel, using MATLAB, according to equation 
(1).     
      NADH Redox Ratio = RR = NADH / FAD              (1) 
 The 2D representation of each eye was then calculated using the maximum 
intensities along the z axis of the NADH redox 3-D volume (maximum projection). In the 
maximum projection method, first a full 3D volume of images was obtained, including 
RR, and then the maximum projection on the volumetric data was performed and the 
histograms were plotted for this maximum projection. The maximum projection is used 
since the entirety of the anatomy has a significant contribution in this representation. A 
histogram of the max projection of RR values in each group was created, and the mean 
(or first moment) of this histogram was calculated according to Eq. (2). 
                              
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Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in x 
and y is 10μm and 10μm. The previously mentioned histograms were calculated for 
quantitative comparison between normal and diseased groups.  
Statistical evaluation of data 
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Data are presented as mean ± SEM. A mixed model 2 x 6 ANOVA with animal group 
(P23H vs. SD) as the between-subjects factor and flash intensities of the scotopic 
intensity series as the within-subjects factor was used to analyze ERG data. A 
Greenhouse-Geisser correction (a-wave =.500; b-wave =.460) was performed as the 
assumption of sphericity was violated for the a-wave (X
2
 = 31.140, p = .006) and b-wave 
(X
2
 = 28.381, p = .016) data. An unpaired Student’s t-test was used for comparing mean 
values of NADH redox ratio and a-wave and b-wave implicit times at 100mcd.s/m
2
. 
Statistical analysis was performed using SPSS 19.0 (SPSS Inc, Chicago, IL) and 
GraphPad Prism 4.0 (GraphPad, La Jolla, CA USA). The level of significance for all 
statistical tests was set at 0.05. 
 
Results 
 In the present study, we used the cryo-fluorescence redox imaging method to 
probe the retinal mitochondrial redox state. The method was performed on P23H 
transgenic eyes and SD normal eyes at postnatal day 30, to determine the effect of disease 
on the NADH RR. This method detects changes in the oxidation state of the 
mitochondrial respiratory chain. Thus, NADH RR can be used as a quantitative marker to 
evaluate the OS in diseased and normal eye tissue. 
  3-D rendering of NADH redox images is generated from representative eye 
sample (not included in this dissertation as  the figure is in the process of submission for 
the cover page of Journal of Biomedical Optics). The optic nerve of the eye can be seen 
in this figure. The 3-D rendering shows the capability of the cryoimager to perform 3-D 
cryofluorescence imaging on intact tissue. 
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 Figure 43 displays, maximum projection images of NADH, FAD, and NADH RR 
for a representative eye in transgenic and SD normal groups. The images show a 
significant decrease in the mean NADH RR of eyes from diseased versus SD normal eye. 
The eyes in the SD normal group (first column in Figure   43) show a lower concentration 
of FAD and a higher concentration of  NADH compared to diseased group (second 
column in  Figure 44). Thus, the NADH RR is higher (more reduced) in eyes from SD 
normal rat eye compared to the eyes from transgenic rats (more oxidized). Sections from 
the P23H transgenic rats consistently demonstrated increased OS as shown in Figure 4 by 
a decreased NADH RR.  
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Figure 43 Representative max projected NADH, FAD and RR images for eyes from 
normal and disease groups. 
 
 Figure 44 shows the NADH redox histograms of a representative eye in each of 
the SD normal and diseased groups. In the diseased group the NADH RR indicates a 
more oxidized biochemical state with a mean value of 0.821 compared with a higher 
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mean value of 1.079 in SD normal eyes. There was a blue shift in histograms from P23H 
transgenic eye versus the normal eye and the NADH redox histogram shows a 24% 
oxidation in the respiratory chain in this group.  
 
Figure 44 A representative histogram for eyes from normal and diseased groups 
comparing Redox Ratio intensity between P23H transgenic retina vs. SD Normal 
retina. Oxidative stress causes more oxidation in the NADH redox histogram 
Figure 45 compares the mean values of the histograms of max projected images 
from SD normal and diseased groups. The results show a significant difference (p <.001) 
between P23H transgenic eyes versus the SD normal  eyes (n=4 in each group). 
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Figure 45  Bar graph plot comparing the mean values of the histograms of max 
projected images from SD and P23H transgenic rat eyes. The results show a 
significant difference between normal and diseased eyes (***p<.001). Error bars: 
SEM; p values were obtained from Unpaired Student’s t- test. 
 
Figure 46 summarizes the differences in photoreceptor function between Sprague 
Dawley rats and P23H-1 transgenic rats. When the function of the photoreceptors (a-
wave amplitude; Figure 46A) and inner retina (b-wave amplitude; Figure 46B) was 
assessed by dark-adapted, full-field flash ERG (scotopic intensity series protocol) at P30, 
there was a linear increase in the ERG amplitude in both non-dystrophic SD and 
dystrophic P23H rats (F(1,14) = 186.970, p <0 .001). The main effect of mean ERG 
amplitudes between non-dystrophic SD and dystrophic P23H rats for a-wave (F(1, 14) = 
161.0, p <.001; Fig. 46A) and b-wave ( F(1, 10) = 35.4, p <.001; Fig. 46B) of the scotopic 
intensity series protocol were significantly different. In agreement with the previous 
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studies, P23H transgene caused a significant decrease in both a-wave and b-wave 
amplitudes compared to the normal SD controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46 A) The mean a-wave amplitude assessed by the scotopic intensity series 
protocol comparing P23H transgenic (■; n=8) and SD normal control (▲; n=8) 
groups  B) The mean b-wave amplitude comparing P23H transgenic (■; n=6) and 
SD normal control (▲; n=6) groups. P23H transgene caused a significant 
decrease in both a-wave (F(1, 14) = 161.0, p < .001; Fig. 46A)  and b-wave  ( F(1, 10) 
= 35.4, p < .001; Fig. 46B) amplitudes at all flash intensities compared to the 
normal SD controls. Error bars: SEM. 
96 
 
 
 
 Figure 47 compares the a-wave and b-wave peak latencies referred to as implicit 
times. P23H transgene caused a significant (P<.01) delay in both a- and b- wave implicit 
times in P23H retina when compared to SD normal controls. The delay and deviations of 
the implicit time topography in retinitis pigmentosa when compared to normal subjects is 
a characteristic diagnostic tool. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47 shows the a-wave implicit time as well as b- wave implicit time 
assessed at 100mcd.s/m2. The implicit times reflecting peak latencies of 
a- and b- waves were significantly (**p<.01) different between P23H 
transgenic and normal SD retina. Error bars: SEM; p values were obtained 
from Unpaired Student’s t- test. 
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Discussion and conclusion 
 
 Rod specific mutations, which are genetically heterogeneous trigger 
photoreceptor cell death by apoptosis in various forms of RP and other inherited retinal 
degenerations. Recent studies suggest that death of cone photoreceptors subsequent to rod 
cell death are due to increased oxidative and nitrosative stress (Shen, Yang et al. 2005; 
Usui, Komeima et al. 2009). The retina is particularly vulnerable to oxidative damage 
since it is one of the highest oxygen consuming tissues of the body and about 90% of 
tissue oxygen is metabolized within the mitochondria (Yu and Cringle 2001). As reported 
in induced and inherited retinal degeneration models, photoreceptors die due to OS, 
mitochondrial dysfunction and apoptosis (Dykens, Carroll et al. 2004). There are several 
potential sources of ROS generation in inherited retinal degenerative diseases that may be 
either caused or exacerbated by reduced oxygen consumption due to the loss or inactivity 
of mutant rod photoreceptors. Markers of oxidative damage to proteins, lipids and DNA 
have been detected in cone photoreceptors in the  transgenic pig model of RP that 
suggesting that as the rod photoreceptors degenerate, there is a reduction in oxygen 
consumption in the outer retina resulting in hyperoxia in the photoreceptor layer with  
subsequent increase in oxidative stress, resulting in cone loss (Cassarino, Swerdlow et al. 
1998; Yu and Cringle 2001). Understanding the biochemical mechanisms involved in 
cone photoreceptor degeneration is important since cone loss is the major reason for 
visual loss in RP.  The above hypothesis is supported by the fact that photoreceptor 
depletion-induced hyperoxia is a factor that makes the degeneration process progressive 
as seen in models of retinal degeneration. Increasing evidence supports the therapeutic 
efficacy of mitochondrial targeted agents including MITO 4565, TUDCA 
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(tauroursodeoxycholic acid), minocycline and cyclosporine A in various models of retinal 
and neurodegenerative disorders (Cassarino, Swerdlow et al. 1998; Dykens, Carroll et al. 
2004; Phillips, Walker et al. 2008; Yang, Kim et al. 2009). 
 The metabolic state of a cell is reflected in mitochondrial oxidative function.  
Mitochondrial oxidative metabolism is an important biomarker for the diagnosis and 
treatment of many disease pathologies, including cancer, autoimmune disorders and 
neurodegenerative diseases
 
(Green and Evan 2002; Todaro, Zeuner et al. 2004). In this 
study, we used a 3-D cryofluorescence redox imaging technique to quantify and compare 
the mitochondrial redox state in normal and diseased retinae.  
 In the presence of hyperoxia, as seen in RP and other inherited retinal 
degenerations, the coenzymes NADH and FADH2 accumulate in their oxidized forms 
(NAD and FAD). We therefore anticipated higher concentrations of FAD and lower 
concentrations of NADH in the P23H retina compared to SD normal retina. It can be seen 
from the maximum projection images in Figure 4 that the FAD concentration is higher 
(brighter images) and NADH concentration is lower (darker images). This results in the 
NADH RR showing a significant decrease in the degenerating eye as compared to the SD 
normal. The difference in the mean values of the two histograms in Figure 5 suggests that 
OS caused by the disease in transgenic eyes is the reason for a shift in metabolic levels of 
the eye tissue and causes the mitochondrial respiratory chain to be more oxidized. The 
24% oxidation in the NADH RR that we observed in the retina of P23H transgenic rat 
model suggests that substantial mitochondrial OS is a significant early cellular event in 
RP. The significant difference in the mean NADH RR of eyes from transgenic rats 
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compared with their appropriate controls (SD normal eyes) suggests that the NADH RR 
can be used as a marker of retinal OS. 
 We observed an increase in signal intensity in the eye samples from the vitreous 
in both NADH and FAD channels that needs to be further investigated and explained. 
Changes in the biochemical composition of vitreous following pathological changes in 
the retina during the degeneration process may be one of the reasons for those isolated 
signals. Collagen, elastin, flavins and lipo-pigments (ceroid and lipofuscin) are some of 
the endogenous tissue fluorophores that has excitation emission spectral overlap with 
NADH (Wagnieres, Star et al. 1998). It has also been shown that upon binding to a 
protein, the quantum yield of NADH increases by four fold (Joseph 2006). Proteomic 
changes in the vitreous humor have been reported in micro vascular pathologies including 
proliferative diabetic retinopathy (Kim, Kim et al. 2007). 
 Our results demonstrate the quantitative capability of an optical cryoimaging 
technique to measure the tissue mitochondrial redox state in the normal and diseased rat 
retina. Our method is a direct analysis of the cellular metabolic state within the 
mitochondrial compartment of the retina of P23H transgenic rat model of Retinitis 
Pigmentosa, which has not previously been reported. Furthermore, the studies presented 
here set the stage for future studies, using ex vivo and in vivo fluorescence imaging of 
mitochondrial redox states of retina to characterize disease progression in various retinal 
dystrophies and to evaluate mitochondria targeted drug regimens that diminish OS. 
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CHAPTER 6 
COMPARISON OF 670 nm vs. 830nm   PHOTOBIOMODUALTION   
USING THREE TREATMENT PARADIGMS       
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To compare the efficacy of 670nm and 830nm NIR photobiomodulation in protecting 
photoreceptors against damage induced by the P23H transgene, three NIR-LED treatment 
paradigms were investigated. The first treatment protocol determined whether NIR PBM 
can rescue photoreceptor function during the critical period (p10-p25) of photoreceptor 
development. The second treatment protocol determined whether NIR PBM can mitigate 
the degenerative process from the onset of the critical period of photoreceptor cell death 
to young adulthood (p10-p 40) and the third treatment protocol determined the ability of 
NIR PBM to rescue remaining photoreceptors (p20-p40) and preserve retinal function in 
young rats in which the majority of rods have degenerated.  
Figure 48 compares the a-wave amplitude (panel A), b-wave amplitude (panel B), the 
average implicit time for both a- and b-wave (panel C) at the initial flash intensity of the 
scotopic intensity series response and the mean total retinal thickness (panel D) for both 
830nm (left panel) and 670nm (right panel) NIR PBM during the critical period of 
photoreceptor development. The main effect of mean ERG amplitudes for the a-wave 
response which reflect photoreceptor activity and b-wave response which  originates 
from post-synaptic neurons was significantly different between P23H and the treated 
group  in 830nm study [a-wave: (F(1,14) = 16.32 , p < .001); b-wave: (F(1,22) = 23.57, p < 
.001)]  when compared to that of the 670nm study [a-wave: (F(1,22) = .396 , p =.536); b-
wave: (F(1,11) = 2.11, p =.173)]. The implicit time at 100mcd.s/m
2 
was significant for both 
a-wave (p<.01) and b-wave (p<.05) in the 830nm study but was not significant with the 
670nm study.  Total retinal thickness decreases as rod photoreceptors degenerate and 
disrupt the cellular architecture of the retina and our results demonstrate that 830nm 
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study significantly attenuated (p<.01) the thinning of retina in SDOCT linear scans. As 
similar trend was observed with 670nm study but was not statistically significant. 
Figure 49 compares the functional and structural changes in P23H transgenic 
retina following NIR PBM by 830nm (left panel) and 670nm (right panel) photons during 
the onset of the critical period of photoreceptor cell death to young adulthood (p10-p 40). 
The main effect of mean ERG amplitudes for a-wave (panel A) response and b-wave 
response  (panel B) was significantly different between P23H and the treated group  in 
830nm study [a-wave: (F(1,14) = 16.63 , p < .01); b-wave: (F(1,14) = 14.6, p < .01)]  when 
compared to that of the 670nm study [a-wave: (F(1,10) = .279 , p =.609); b-wave: (F(1,11) = 
2.01, p =.172)]. The implicit time for a- and b-waves in both 830nm study and 670nm 
study was not statistically significant (panel C).  As 670nm PBM did not preserve the 
retinal structure in the p10-p25 study, SD-OCT imaging was not conducted in p10-p40 
and the p20-p40 study.  830nm PBM continued to preserve the structural integrity (panel 
D) of the retina in the p10-p40 study, but was not significantly different from the non-
treated P23H group. 
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Figure 48  compares the functional and structural changes in P23H transgenic 
retina following NIR PBM by 830 and 670 nm photons during the critical period 
of photoreceptor degeneration (p10-p25). Panel A compares the a-wave amplitude 
and panel B compares the b-wave amplitude between P23H (■) and 830 nm 
treated group (▲, left), P23H (■) and 670 nm treated group (▲, right) 
respectively. The main effect for a-wave and b-wave between the groups are 
significantly different [a-wave: (F(1,14) = 16.32 , p < .001); b-wave: (F(1,22) = 23.57, 
p < .001)]  in 830 nm treated group when compared to that of the 670 nm treated 
group [a-wave: (F(1,22) = .396 , p =.536); b-wave: (F(1,11) = 2.11, p =.173)]. Panel C 
compares the implicit time for a-wave and b-wave at 100mcd.s/m
2
. 830 nm 
treatment caused a significant difference in a-wave (p<.01) and b-wave (p<.05) 
when compared to the 670 nm group even though a trend was observed in the 
later. Panel D shows total retinal thickness measured by SD-OCT demonstrating 
retinal structural integrity  which was significantly different (p<.01)  in 830 nm 
treated group at both 0 degree and 90 degree linear scans when compared to P23H 
group but 670 nm treatment demonstrated a trend without a statistically 
significant result. Error bars: SEM. 
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Figure 49 compares the functional and structural changes in P23H transgenic 
retina following NIR PBM by 830 and 670 nm photons during the onset of the 
critical period of photoreceptor cell death to young adulthood (p10-p 40). Panel A 
compares the a-wave amplitude and panel B compares the b-wave amplitude 
between P23H (■) and 830 nm treated group (▲, left), P23H (■) and 670 nm 
treated group (▲, right) respectively. The main effect for a-wave and b-wave 
between the groups are significantly different [a-wave: (F(1,14) = 16.63 , p < .01); 
b-wave: (F(1,14) = 14.6, p < .01)]   in 830 nm treated group when compared to that 
of the 670 nm treated [a-wave: (F(1,10) = .279 , p =.609); b-wave: (F(1,11) = 2.01, p 
=.172)]. Panel C compares the implicit time for a-wave and b-wave at 
100mcd.s/m
2
 and there was no statistically significant difference between P23H 
and both treatment groups. Panel D shows total retinal thickness measured by SD-
OCT linear scans representing retinal structural integrity which was not 
statistically significant between P23H and 830 nm treated group. Error bars: 
SEM. 
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Figure 50 compares the functional and structural changes in P23H transgenic 
retina following NIR PBM by 830 and 670 nm photons during the later stage 
(p20-p 40) to rescue remaining photoreceptors. Panel A compares the a-wave 
amplitude and panel B compares the b-wave amplitude between P23H (■) and 
830 nm treated group (▲, left), P23H (■) and 670 nm treated group (▲, right) 
respectively. The main effect for a-wave and b-wave between the groups are 
significantly study [a-wave: (F(1,22) = 4.60 , p < .05); b-wave: (F(1,20) = 5.85, p < 
.05)]  in 830 nm treated group when compared to that of the 670 nm treated [a-
wave: (F(1,10) = .00 , p =.99); b-wave: (F(1,10) = 0.28, p =.608)]. Panel C compares 
the implicit time for a-wave and b-wave at 100mcd.s/m
2
 and there was no 
statistically significant difference between P23H and both treatment groups. Panel 
D shows total retinal thickness measured by SD-OCT linear scans representing 
retinal structural integrity. 90 degree linear scans were statistically significant 
between P23H and 830 nm treated group (p < .05) but in contrast 0 degree scans 
were not statistically significant (p =.05). Error bars: SEM. 
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Figure 50 compares the functional and structural changes in P23H transgenic retina 
following NIR PBM by 830 (left panel)  and 670 nm (right panel) photons during the 
later stage (p20-p 40) to rescue remaining photoreceptors.  The main effect of mean ERG 
amplitudes for a-wave response  (panel A) and b-wave response (panel B)  was 
significantly different between P23H and the treated group in the 830nm PBM study [a-
wave: (F(1,22) = 4.60 , p < .05); b-wave: (F(1,20) = 5.85, p < .05)]  as seen in previous two 
treatment paradigms when compared to that of the 670nm study [a-wave: (F(1,10) = .00 , p 
=.99); b-wave: (F(1,10) = 0.28, p =.608)].  There was no difference in a-wave or b-wave 
implicit times between the 670 nm and the 830 nm treatments. (panel C). Interestingly we 
observed better preservation of retinal structure with 830nm PBM in the 90 degree linear 
scans (p<.05), even though treatment started in young adult rats which has the majority of 
rods degenerated (paned D). This observation provides new insights into the ability of 
PBM to preserve the secondary retinal structures and enhance self-renewal and repair of 
the retinal cells that generally undergo degeneration as rod photoreceptors die. 
In summary the results demonstrated in this study shows that 830nm PBM generates 
more robust cellular and physiological response in P23H transgenic rats when compared 
to the 670nm PBM in three treatment paradigms. 
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PHOTOBIOMODUALATION ATTENUATES RETINAL 
DEGENERATION IN THE P23H RAT MODEL OF RETINITIS 
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Introduction 
Retinitis pigmentosa (RP) is a hereditary retinal degenerative disorder and the 
most common cause of inherited blindness in the developed world, with an estimated 1.5 
million patients worldwide and a prevalence of one in 5000 individuals worldwide
1,2
. 
Clinically, RP is characterized by nyctalopia in the initial stages resulting from loss of 
rod photoreceptors followed by patchy loss of peripheral vision in daylight which 
progresses towards the center leading to tunnel vision resulting from secondary loss of 
cone cells.  Fundus images of patients with RP reveal attenuation of retinal vessels, waxy 
palor in the optic disc and pigment deposits in the peripheral retina that resemble bony 
spicules
3
. Although the majority of RP cases are monogenic, the disease is characterized 
by its genetic heterogeneity and more than 40 genes have been associated with RP. RP 
can be inherited in an autosomal dominant, recessive, X-linked or mitochondrial mode
4
. 
RP is associated with gene defects in proteins involved in the visual transduction cascade, 
RPE function, photoreceptor structure and RNA splicing
4
. The first gene abnormality 
reported in RP was a single-base substitution in codon 23 of rhodopsin gene (RHO). This 
mutation [proline 23 histidine] (P23H) accounts for 12% of autosomal dominant RP in 
US
5
. 
Rod and cone photoreceptors are the most metabolically active cells in the CNS 
with a high rate of oxygen consumption.  Cones are more metabolically active than rods; 
however rods greatly outnumber cones in the retina. As rod photoreceptors degenerate in 
clinical and experimental RP, there is a decrease in oxygen consumption in the retina that 
results in increased oxygen tension
6
.  Choroidal vessels are poorly autoregulated and 
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cannot compensate for this increased oxygen tension, resulting in outer retinal hyperoxia 
and an altered intracellular redox equilibrium leading to increased oxidative stress
7
.  
Considerable evidence supports a key role for mitochondrial dysfunction and 
oxidative damage in the pathogenesis of photoreceptor cell death in RP and other retinal 
degenerative disorders
8,9
.  Despite the degree of genetic heterogeneity, human retinal 
dystrophies have been associated with profound loss of retinal antioxidant systems and 
cytoprotective factors thus compromising the ability of retinal neurons and glia to protect 
against oxidative damage leading to apoptotic cell death
10,11
. Moreover, mitochondrial 
dysfunction leading to increased oxidative stress and abnormal regulation of apoptosis 
are characteristic findings of many inner and outer retinal  disorders including Leber’s 
hereditary optic neuropathy (LHON), glaucoma, age-related macular degeneration 
(AMD) and diabetic retinopathy
12,13,14. 
Photobiomodulation (PBM) is defined as a process by which cellular signaling 
pathways are activated when photons interact with cellular photoacceptor molecules 
leading to physiological changes in the cell. Treatment of tissue with monochromatic 
photons in the far-red to near-infrared (NIR) region of the spectrum (630-1000 nm) has 
been shown to attenuate the harmful effects of neuro- and developmental toxins and 
improve recovery from ischemic reperfusion injury in the heart
15-18
.  PBM has also been 
shown to attenuate degeneration in the injured retina and optic nerve, ameliorate the 
retinotoxic effects of methanol-derived formic acid in rodents and improve recovery in 
experimental and clinical stroke
19-23
. 
 Recent studies from our laboratory have demonstrated that NIR photons 
decreased the concentrations of cytotoxic and pro-apoptotic factors and reduced cell 
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death and inflammation in rodent models of light-induced retinal degeneration and 
multiple sclerosis
24,25.  Fitzgerald and colleagues demonstrated that NIR photons 
delivered transcranially to the injury site in an in vivo model of partial optic nerve 
transection resulted in a decrease in secondary oxidative stress in astrocytes, an increase 
in NG-2 immunopositive oligodendrocyte precursor cells and restored visual function
22
. 
Increasing evidence indicates that cytochrome c oxidase, the terminal electron 
acceptor of the electron transport chain, is a key photoacceptor molecule mediating the 
therapeutic actions of photobiomodulation
26
. The interaction of NIR photons with 
cytochrome c oxidase increases the mitochondrial membrane potential (ΔΨ) and proton 
gradient in the intermembrane space of the mitochondria
27
, modifies NADH linked 
dehydrogenase reactions
28
 and alters the rate of ADP/ATP exchange
29
 resulting in the 
activation of intracellular signaling cascades which culminate in improved mitochondrial 
function, increased synthesis of cytoprotective factors and cell survival
19
.  Microarray 
studies have identified genes and noncoding RNAs involved in the neuroprotective 
actions of NIR-PBM in light induced retinal degeneration model. These studies 
demonstrated significant up-regulation of gene expression in pathways involved in 
mitochondrial energy production and antioxidant cellular protection and down-regulation 
of gene expression in pathways involved in apoptotic cell death
30
.  
Mitochondrial dysfunction is a hallmark finding in retinal and neurodegenerative 
disorders and PBM has been shown to improve cellular mitochondrial energy metabolism 
in cultured cells and in animal models of disease.  The purpose of this investigation was 
to test the hypothesis that 830nm photobiomodulation would slow disease progression 
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and improve retinal metabolic state in an animal model of retinal dystrophy, the P23H 
transgenic rat. 
Materials and Methods 
Animals 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee (IACUC) and were conducted in accordance with the ARVO (The 
Association for Research in Vision and Ophthalmology) statement for the use of animals 
in ophthalmic and vision research and with the National Institutes of Health regulations.  
Heterozygous P23H-1 transgenic rats, the offspring P23H-1 homozygotes (Retinal 
Degeneration Rat Model Resource, UCSF) and Sprague-Dawley (SD) albino rats (Harlan 
Sprague Dawley, Madison, WI) were used as the model of RP. All animals were housed 
and bred in an AAALAC approved animal at the University of Wisconsin-Milwaukee. 
Rats were fed ad libitum and maintained in a temperature and humidity-controlled 
environment under dim cyclic light, 12-hour light/12-hour dark cycle, with an average 
illuminance of 5 to 10 lux inside the cage. 
NIR Treatment Protocol 
P23H-1 transgenic rat pups were treated with 830 nm LED arrays engineered to 
eliminate heat (GaAlAs LED arrays, QBMI Photomedicine, Barneveld WI). Rat pups 
were hand-held by the investigator or placed in a plexiglass restraint device and the 830 
nm LED array was positioned directly over the animal’s head at a distance of 2 cm 
exposing both eyes. Treatment protocol consisted of irradiation at 830 nm for 180 
seconds at power intensity of 25mW/cm
2
 and an energy density of 4.5 joules/cm
2 
at the 
surface of the cornea.  Sham-treated P23H-1 transgenic pups were handled in the same 
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way, except that they were not exposed to the LED array. Animals in the NIR-PBM 
treated group were treated once a day for 5 days per week from p10 to p25. 
Electroretinography 
Photoreceptor function was assessed by full-field flash-evoked 
electroretinography (ERG).  At p30, animals were dark-adapted overnight and prepared 
under red dim light. Animals were anesthetized with a ketamine and xylazine cocktail 
(100 mg/kg and 5 mg/kg respectively, ip) and placed on a heating pad at 37°C during 
recordings.  Pupils were dilated with 0.1% atropine and mild topical anesthesia 
(proparacaine 0.5%).  Full-field ERGs were obtained in a Ganzfeld dome (76 mm 
diameter Flash Dome with 55 mm aperture) using nylon coated gold thread electrode 
placed on the corneal surface, overlaid with 1% methylcellulose and a contact lens. A sub 
dermal needle reference electrode and a ground needle electrode were placed in the cheek 
and tail respectively. A high-intensity flash unit (HMsERG instrument, Retvet Corp, MO) 
was used to provide flash intensities (ranging from 10 mcd.s/m
2
 to 25000 cd.s/m
2
) for 
scotopic intensity series response measurements. The ISCEV protocol was also employed 
to examine rod-mediated and rod and cone-mediated responses.  Signals were amplified, 
digitized and averaged using ERG view 2.5 software (RetVet Corp. Inc., Columbia, MO).  
A custom designed Faraday cage was employed to block 60 cycle electrical noise. The 
amplitudes and latencies of the a-waves (photoreceptor responses) and b-waves (bipolar 
cell and Muller cell responses) were fit to a computational model to determine 
transduction parameters for photoreceptor responses. 
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Spectral Domain Optical Coherence Tomography (SD-OCT) imaging 
High-resolution scans were performed at p30 to assess retinal morphology using 
SD-OCT (Bioptigen Inc, Research Triangle Park, NC). Animals were anesthetized with a 
ketamine and xylazine cocktail (i.p., 50:5 mg/kg body weight) and were placed on a 
custom made six-axis animal alignment system. Both eyes were imaged in a single 
session after dilation of pupil (1% Atropine sulphate) and hydration of cornea (Systane 
ultra, polyethylene glycol 400, 0. 4%). The fundus imaging camera in the optical head of 
the OCT provided initial alignment for the light source during the real time aiming. Final 
positioning was guided by monitoring and calibrating the real-time OCT image of the 
retina formed. The optic nerve head (ONH) was used as a landmark (Figure 51a and 
Figure 51b) and linear (1000 A-scans/B-scan, 80 B-scans) and volume scans (750 A-
scans/B-scan, 250 B-scans/volume) per eye were captured and saved using the 
Bioptigen's InVivoVue
TM
 software. For the linear scans, the B-scans were registered and 
averaged as previously described
31
 using ImageJ 32 (National Institutes of Health, 
Bethesda, MD) and segmentation of retinal layers for total thickness were determined 
using an algorithm generated in MatLab (The MathWorks, Inc. , Natick, MA).  The 
difference in reflectivity of retinal layers was used in generating longitudinal reflectivity 
profile
33
 (LRP, Figure 51c) and based on the LRP at fixed locations  on either side for the 
ONH, outer nuclear layer thickness (ONL) was determined as demonstrated in Figure 
51d. 
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Figure 51 a and 51 b shows the ONH landmark used for SDOCT imaging. Figure 51c 
shows the difference in the reflectivity of retinal layers from which Longitudinal 
Reflectivity Profile (LRP) is generated. Low reflecting layers in the linear scan 
correspond to nuclear layers and high reflecting layers correspond to synaptic layers in 
the retina
31, 53
. NFL, nerve fibre layer; GCL, ganglion cell layer; OPL, outer plexiform 
layer; ONL, outer nuclear layer; IS/OS, inner segment/outer segment junction; BM, 
Bruch's membrane. Figure 51 d represents the LRP lines 50Px apart on either side of the 
ONH (100Px width) used for characterizing the ONL thickness.  
 
 
 
 
b a 
c d 
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Tissue Collection and Toluidine Blue Staining 
Animals were euthanized at p30 by CO2 inhalation and the eyes were rapidly 
enuculeated for histological evaluation.  The eyes were marked at superior position (in 
the corneal limbus) using a surgical cautery and immersion-fixed in 4% 
paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) at pH 7.4 for 2 h.  Sections 
(10 µm) were stained with toluidine blue and examined using an Olympus Axioskop 
microscope to evaluate structural changes in the retina as described previously
24
. 
Measurement of ONL thickness 
The number of surviving photoreceptors was quantified by counting the rows of 
photoreceptor nuclei in the ONL in digital images of toluidine blue stained resin sections 
at three locations (100 µm, 200 µm and 300 µm from the optic nerve head) on the 
superior pole and inferior pole of the optic nerve as previously described34. 
Freezing and embedding tissue for Optical Cryo Imaging 
Retinal metabolic state was assessed using a novel optical redox-sensitive 
cryoimaging technique. Animals were euthanized at p30, and their eyes were harvested 
and frozen rapidly for low temperature cryoimaging.  The eyes were embedded in a 
customized black mounting medium (Figure 32) to remove the background fluorescence 
and scanned by the cryoimager.  The cryoimager (Figure 33) is an automated image 
acquisition and analysis system consisting of software and hardware designed to acquire 
fluorescence images of tissue sections. The excitation light source is a 200W mercury arc 
lamp filtered at the excitation wavelength of  NADH and FAD, 336 nm and 470 nm, 
respectively. The emission wavelengths are 450 nm and 520 nm for NADH and FAD and 
respectively.  At each slice, a CCD camera records a fluorescence image of the tissue 
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block. The resolution in the z direction of microtome slices can be as small as 5 µm. For 
this study, we used a resolution of 10 m in the z direction, which resulted in ~ 400 z-
slices per eye. 
FAD and NADH autofluorescence images from each group of eyes were 
processed using Matlab. The composite images were created using all the image slices for 
each eye, for both NADH and FAD signals. The ratio of NADH and FAD, known as the 
NADH redox ratio
35
, was calculated voxel by voxel, using Matlab, according to equation 
(1).     
Redox Ratio = RR = NADH / FAD        (1) 
The 2D representation of each eye was then calculated using the maximum 
intensities in the z axis of the NADH redox 3D volume (not included in this dissertation 
as   the figure is in the process of submission for the cover page of Journal of Biomedical 
Optics). In the maximum projection method, first a full 3D volume of images was 
obtained, including RR, and then the maximum projection on the volumetric data was 
performed and the histograms were plotted for this maximum projection. The maximum 
projection is used since the entirety of the anatomy has a significant contribution in this 
representation. A histogram of the max projection of RR values in each group was 
created, and the mean (or first moment) of this histogram was calculated according to Eq. 
(2). 
            
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Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in 
x and y is 10μm and 10μm. The previously mentioned histograms were calculated for 
quantitative comparison between P23H-sham and P23H-NIR-treated groups. 
Data Analysis 
Data are presented as mean ± SEM. A mixed model ANOVA (Greenhouse-
Geisser correction was performed whenever the assumption of sphericity was violated), 
MANOVA, 1-way ANOVA (Kruskal-Wallis test) and Student's t-test performed, as 
appropriate. Statistical analysis was performed using SPSS 19.0 (SPSS Inc, Chicago, IL) 
and GraphPad Prism 4.0 (GraphPad, La Jolla, CA USA). The level of significance for all 
statistical tests was set at .05. 
Results 
830 nm photobiomodulation preserved retinal function in the P23H rat  
Figure 52 summarizes the changes in photoreceptor function in P23H transgenic 
retina following photobiomodulation by 830 nm NIR photons during the critical period 
(p10-p25) of photoreceptor loss.  When the function of the photoreceptors (a-wave 
amplitude; Figure 52 a) and inner retina (b-wave amplitude; Figure 52 b) was assessed by 
dark-adapted, full-field flash ERG (scotopic intensity series protocol) at p30, there was a 
linear increase in the ERG amplitude in both NIR treated P23H and non-treated P23H 
groups.  In agreement with previous studies, the P23H transgene caused a profound 
decrease in both a-wave and b-wave amplitudes compared to the normal SD controls 
(data not shown) that was rescued by treatment with 830nm NIR photons. 
Figure 52 a summarizes the comparison of mean a-wave ERG amplitude over a 
range of flash intensities (from 10 mcd.s/m
2
 to 25000 cd.s/m
2
) between NIR-treated and 
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sham treated P23H-1 transgenic rats.  The a-wave amplitude curve in the NIR-treated 
animals was significantly greater (F(1, 14) = 16.32, p < .001; Fig. 52a) than that measure in 
the sham-treated animals indicative of protection of photoreceptor function by 830 nm 
PBM. The effects of NIR treatment on the functional response post synaptic to 
photoreceptors was assessed by measuring the b-wave amplitude over the same range of 
flash intensities in NIR-treated and sham-treated rats.  Figure 52 b shows the mean b-
wave amplitude in each treatment group.  At each intensity the amplitude of the b-wave 
was 50% greater in the NIR-treated animals compared to the sham-treated animals and 
was significantly different (F(1, 22) = 23.57, p < .001; Fig. 52b). 
Figure 52 c shows the average a-wave amplitude reflecting the rod-only response 
in the ISCEV protocol. The rod-only response was significantly greater in the NIR treated 
retina compared to the sham-treated retina (14.8 ± 2.2 µV vs. 8.8 ± 0.7; p < .05 µV, n=4).  
Figure 52 d shows the average a-wave amplitude reflecting the standard rod and cone 
response in the ISCEV protocol.  The a-wave amplitude of the rod and cone-mediated 
response was also significantly greater in the NIR-treated compared to the sham-treated 
animals (69.2 ± 3.2 µV vs. 59.3 ± 0.8 µV;  p < .05, n=3). 
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Figure 52a  shows the mean a-wave amplitude and figure 52b shows the mean b-
wave amplitude assessed by the scotopic intensity series protocol comparing 
P23H transgenic retina (■) and 830 nm treated P23H retina (▲). 830 nm caused a 
significant increase in both a-wave (F(1, 14) = 16.32, p < .001; n=8, Fig. 52a) and b-
wave amplitudes ( F(1, 22) = 23.57, p < .001; n=12,  Fig. 52b) at all flash intensities 
compared to the P23H group. Figure 52c shows the ISCEV protocol for Rod only 
response (a wave; flash strength -10mcds/m
2
) which was significantly (p<.05)and 
Figure 52d shows ISCEV protocol for Standard Rod and Cone response (a wave; 
flash strength -3000 mcds/m
2
). Error bars: SEM. 
 
a b 
c d 
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830 nm photobiomodulation preserved retinal structure in the P23H rat 
Figure 53 a shows a comparison of the total retinal thickness of P23H transgenic 
group with the in NIR-PBM treated group using SD-OCT at p30. In our studies the 
preservation of total retinal thickness was evident in the in NIR-PBM treated group 
compared to the non-treated group. The mean total retinal thickness was significantly 
(p<.01) higher in NIR-PBM treated group (171.1 ± 2.0 µm, n=5) when compared to the 
P23H group (169.2 ± 3.1µm, n=5). Figure 53 b compares the ONL thickness in µm at 
identical locations on either side of the ONH. The ONL thickness of NIR-PBM treated 
group was significantly greater (F(1, 8) = 12.23, p < .01; Fig. 53b) compared to the sham-
treated group across the entire scan. 
Figure 54 shows histologic labeling of plastic sections stained with toluidine blue, 
which was used to detect surviving photoreceptors in the retina.  Histomorphometry 
demonstrated that the P23H transgene led to structural damage in the outer retina. The 
ONL was disorganized and there was loss of photoreceptor nuclei and thinning of ONL 
(Figure 55). The cumulative effect of photoreceptor cell death was assessed by the 
measurement of the ONL thickness (Figure 55). The number of nuclei in the superior 
segment of the ONL was significantly greater in the NIR-PBM treated group compared 
the non-treated group and a similar trend was seen in the inferior segment of the eye. 
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b 
Figure 53a and b compares the total retinal thickness and ONL thickness 
respectively from SD-OCT linear scans (1000 A-scans/B-scan, 80 B-scans). Total 
retinal thickness was significantly (p < .05; Fig. 53a) higher in NIR-PBM treated 
group when compared to the P23H group. The ONL thickness of NIR-PBM 
treated group (▲) derived from Longitudinal Reflectivity Profile (LRP) was 
significantly greater (F(1, 8) = 12.23, p < .01; Fig.53b) compared to the sham-
treated group (●) across the entire scan. 
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Figure 54 compares the representative images of retinal sections stained with 
toluidine blue between sham-treated group and the NIR-PBM treated group. The 
ONL in the NIR-PBM treated group is more organized and symmetrically packed 
when compared to the sham-treated which was highly disrupted and disorganized. 
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Figure 55 shows quantitative analyses of the ONL thickness sampled across the 
retina from the superior to inferior edge (n = 4). ONL thickness in NIR-PBM 
treated group is significantly greater compared to the P23H group. Error bars: 
SEM. 
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Efficacy of 830 nm photobiomodulation in P23H transgenic retina monitored by a 
longitudinal study  
Figure 56 and 57 summarize the changes in retinal structure over time following 
NIR-PBM using SD-OCT. The retinoprotective effects of NIR PBM administered in 
P23H transgenic rats during the critical period (p10-p25) diminishes as the animal 
matures and statistically significant difference (p<.01) with the non-treated group was 
found only at the time period, p25.  At p25, the average total retinal thickness of P23H-
NIR group was 173.7 ± 2.0 µm compared to 159.6 ± 1.89 µm of the non-treated group. 
However there was an increase trend in the total retinal thickness at p32 (161.6 ± 1.3 µm 
vs. 155.1 ± 0.57 µm), p39 (156.3 ± 1.3 µm vs. 153.3 ± 1.8 µm) which diminishes at p80. 
 
 
 
 
 
 
 
Figure 6a 
 
Figure 56 compares the total retinal thickness between NIR-PBM treated group 
and sham-treated group monitored in a longitudinal study using SD-OCT. The 
retinoprotective effects of NIR PBM diminishes as the animal matures and 
statistically significant difference (p<.01) with the non-treated group was found 
only at the time period, p25.  Error bars: SEM.  
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Figure 57 compares representative linear scans at p18, p25, p32, p39 and p80 
 
830 nm photobiomodulation preserved the mitochondrial redox state of the P23H 
retina. 
Figure 58  displays, from left to right, maximum projection images of NADH, 
FAD, and NADH -RR (NADH/FAD) for a representative retina in normal (SD), 
transgenic (P23H) and NIR treated (P23H-NIR) groups.  The retina in the control group 
(first column in Figure 58) showed a lower concentration of FAD and a higher 
concentration of NADH compared to P23H transgenic retina (second column in Figure 
58).  Thus, the NADH RR is higher (more reduced state) in retina from normal SD eyes 
compared to the eyes from P23H transgenic rats (more oxidized) suggesting the role of 
increased oxidative stress and dysfunctional mitochondria in the P23H transgenic retina. 
Sections from NIR-PBM treated group (third column in Figure 58) consistently 
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demonstrated lower concentrations of FAD, higher concentration of NADH and higher 
NADH RR compared to P23H transgenic retina demonstrating an altered mitochondrial 
redox state following NIR-PBM, suggesting decrease in oxidative stress. 
Figure 58 (lower panel) shows the NADH redox histograms of a representative 
eye in each normal, P23H transgenic and NIR-PBM treated groups. In the P23H group 
the NADH RR indicates a more oxidized mitochondrial redox state with a mean value of 
0.80 ± 0.1 compared to a higher mean value of 1.2 ± 0.4 in normal control SD eye
7
. 
NADH redox histogram for the representative NIR-PBM eye demonstrated a shift to the 
right with a mean value of 1.02 ± 0.2. 
Figure 59 compares the mean values of the NADH RR histograms of max 
projected images from normal, P23H and NIR-PBM treated groups. The mean NADH 
RR reveals a significant decrease (p<.001) in P23H transgenic eyes compared to normal 
SD eyes suggesting an increased accumulation of ROS and mitochondrial dysfunction 
leading to accumulation of oxidized forms (NAD and FAD) of the mitochondrial 
coenzymes NADH and FADH as a result of the progressive retinal degeneration in the 
P23H transgenic retina.  830 nm irradiation of the P23H retina significantly up regulated 
the NADH RR (p<.01) by increasing the reduced NADH and decreasing FAD. These 
results support the previous studies suggesting the ability of NIR-PBM to decrease 
oxidative stress and improve mitochondrial function in progressive retinal and 
neurodegenerative disorders
22,19
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Figure 58  Upper panel shows a representative max projected NADH (upper 
panel), FAD (middle panel) and RR images (lower panel) for normal (SD), P23H 
transgenic and 830 nm treated transgenic eyes. Lower panel shows a 
representative NADH redox histogram for eyes comparing normal (SD), P23H 
transgenic and 830 nm treated transgenic eyes 
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Figure 59 represents bar graph plot comparing the mean values of the histograms 
of max projected images from SD, P23H transgenic and 830 nm treated P23H 
transgenic rat eyes. The results show a significant decrease in the ratio between 
normal and diseased eyes (**p<.01) which is reversed to normal by 830 nm 
treatment (*p <.01). Error bars: SEM. 
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Discussion 
Even though photobiomodulation by NIR photons are extensively used by 
researchers to demonstrate preservation and stimulation of cellular events in various 
clinical and experimental animal models the use of photobiomodulation is still 
controversial and debated because of the incomplete knowledge of the mechanism of 
action and the differences in the treatment parameters used by various investigators like 
range of wavelength, dose, and the nature of light source- Laser vs. non-coherent light ; 
polarized vs. unpolarized; pulsed vs. continuous wave 36-39. The altered kinetics of the 
photoacceptor molecule (cytochrome c oxidase) after NIR photon interaction and how it 
alters the mitochondrial redox state that triggers secondary signaling cascades which 
culminate in improved mitochondrial function remains a ‘‘black box’’ and future 
experiments should emphasize to resolve the above issues. 
This report demonstrates that 830 nm PBM can ameliorate the disease progression 
in the P23H rat model of RP. Recent studies have demonstrated the neuroprotective 
action of photobiomodulation in several experimental models of progressive degenerative 
disease including Parkinson’s disease40,41, Alzheimer's disease42, multiple sclerosis25, 
light-induced retinal degeneration
24,23
 and age-related retinal inflammation
40, 43,41
. 
Clinical studies have confirmed the therapeutic potential of photobiomodulation at doses 
ranging from 3 to 6 J/cm
2
 in radiation and chemotherapy-induced mucositis and 
stroke
20,44,45,46
. A substantial body of evidence demonstrates that mitochondria are the 
initial site of action of near-infrared photons leading to mitochondrial repair, increased 
ATP production, attenuation of oxidative stress and induction of transcription 
factors
47,22,30,48,43
.  In vitro studies in our laboratory and by other investigators have 
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shown that near-infrared radiation interacts with the key mitochondrial enzyme of the 
electron transport chain, cytochrome oxidase, triggering signaling mechanisms that result 
in improved mitochondrial energy metabolism, antioxidant production and cell survival
18, 
19, 49
.   Moreover,  NIR photon  irradiation has been shown to increase electron transfer in 
purified cytochrome oxidase
50
 and up regulate cytochrome oxidase activity in cultured 
neuronal cells
51
.  A similar pattern of thinning of ONL and severely distorted retina was 
reported in a light-induced retinal degeneration model where NIR-PBM was shown to 
preserve the retinal structure
24
. 
Photobiomodulation promotes retinoprotection 
Our findings demonstrate that 830 nm photobiomodulation during the critical 
period (p10-p25) of photoreceptor degeneration in P23H transgenic rats protected against 
the loss of photoreceptor function and preserved the structural integrity of retina. Both a- 
and b-wave amplitudes were significantly greater in NIR treated animals indicative of a 
protection of photorecptor function.  The functional protection demonstrated in this 
manuscript agrees with that reported by Albarracin et al
24
 in a light-induced retinal 
degeneration model. The in vivo imaging studies using SD-OCT corroborate the 
histology data showing that ONL thickness was significnatly preserved in the NIR-
treated animals. Morover better nuclear packing and more even arrangement in the ONL 
was observed in the NIR treated retina compared to that of the sham-treated retina.  
The longitudinal study measuring the total retinal thickness demonstrated that the 
maximum protection is achevied if the photobiomodulation is applied during the critical 
period. Photobiomodulation treatment parameters used in the study are based on those 
used effectively by other researchers and the lens transmission spectral studies on albino 
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rat lens demonstrate that the dose delivered on the surface of the lens and cornea will be 
transmitted between 90 and 100%
52,43
. Importantly, there was no evidence of damage to 
the normal, nonchallenged retina after NIR PBM. 
To the best of our knowledge, there has been no other study that has examined 
NADH/FAD RR expression in intact eye tissue before and after NIR PBM.  This method 
demonstrates a direct analysis of the cellular metabolic state within the mitochondrial 
compartment of the retina. The two endogenous fluorophores in tissue that reflect cellular 
metabolism in the electron transport chain are NADH (transfers electrons to molecular 
oxygen) and FAD (electron acceptor).  Our studies demonstrate that in P23H transgenic 
retina there is a greater concentration of FAD and lower concentration of NADH 
compared to normal SD retina indicative of the presence of oxidized mitochondria.  In 
the animals treated with 830nm light, there was a significant reversal in the FAD and 
NADH signals reflected in the NADH RR and indicative of protection of normal 
mitochondrial function and a reduction of oxidative stress.  
Clinical Significance 
The results of this study demonstrate retinoprotection mediated by NIR-PBM in a 
well-established rodent model of RP. This protection was evident in structural, functional 
and metabolic studies. Based on these findings, we suggest that NIR-PBM may represent 
an innovative therapeutic approach for the treatment of retinal injury and the treatment of 
retinal diseases, including AMD, glaucoma, diabetic retinopathy, and LHON where 
mitochondrial dysfunction and oxidative stress play a central role in the pathology.  
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CHAPTER 8 
DISCUSSION AND CONCLUSIONS 
 
Taken as a whole, the When taken together the studies presented in this thesis provides 
novel insights into the putative mechanism for NIR PBM involving mitochondria which 
leads to retinoprotective effects and emphasize the importance of harnessing the capacity 
of damaged cells to self-repair for the treatment of inherited retinal degenerations like RP, 
for which no current treatment strategies are available.  
The current study was designed based on the growing body of evidence that exposure of 
tissue to low energy photon irradiation in the far-red (FR) to near-infrared (NIR) range of 
the spectrum (630-1000 nm) interacts with the mitochondrial enzyme cytochrome oxidase 
inducing a cascade of signaling events that culminate in improved cell survival.  FR/NIR 
light has been shown to restore the function of damaged mitochondria, up-regulate the 
production of cytoprotective factors and prevent apoptotic cell death in clinical and 
experimental models of neurodegenerative diseases (Eells, Wong-Riley et al. 2004; Wong-
Riley, Liang et al. 2005; Desmet, Paz et al. 2006; Fitzgerald, Bartlett et al. 2010). 
The current studies have assessed the use of NIR PBM in non-dystrophic animal model.  
These studies showed that PBM did not alter the functional and structural integrity of the 
retina and support the safety of PBM which is essential to advance the therapy to clinical 
use.  In a non-dystrophic animal model there was no significant difference in structural 
integrity and the functional response of the retina between active treatment group and the 
sham control group. This result is of significant clinical importance and similar results are 
reported in clinical trials in the treatment of radiation-induced mucositis and stroke 
149 
 
 
(Lampl, Zivin et al. 2007) (Whelan, Connelly et al. 2002). Studies on the efficacy of NIR 
PBM in non-dystrophic animal model support the hypothesis by our collaborators and 
other investigators that preconditioning events may be triggered in healthy non challenged 
retina at the cellular level by NIR PBM that leads to altered regulation of damaging genes 
that respond differently in the presence of any cellular stress events. Lack of any apparent 
effect was demonstrated in the sham control group after exposure to NIR photons in light-
induced retinal degeneration and methanol-induced retinal cytotoxicity models (Eells, 
Henry et al. 2003) (Albarracin, Eells et al. 2011).  
Mitochondria is shown to selectively absorb wavelengths 670 nm and 830 nm of the far-
red to near-infrared range of the electromagnetic spectrum (Greco, Guida et al. 1989). 
Using action spectrum studies, Wong-Riley et al. demonstrated that 670-nm and 810-nm 
photon irradiation rescued visual cortical neurons from cyanide-mediated cytotoxicity 
(Wong-Riley, Liang et al. 2005). Karu et al. reported that the mitochondrial photoacceptor 
molecule, cytochrome c oxidase has distinct absorption bands in the red (~665 nm) and in 
the NIR (~810 nm) region of the electromagnetic spectrum (Karu, Pyatibrat et al. 2005).  
The work presented has shown that the effect of 830nm PBM is more robust than 670 nm  
PBM in preserving retinal function and structural integrity in P23H transgenic model of 
RP. Recently Albarracin et al. demonstrated that 670nm PBM attenuated bright-light 
induced retinal degeneration in albino rats (Albarracin, Eells et al. 2011).  In our studies 
using the P23H model of retinal degeneration we did not see protection with 670 nm PBM.  
An important difference in the two studies is the dose of the light.  In our study, rats were 
treated for 90 sec at 60 mW/cm
2
 resulting in a dose of  5.4 J/cm
2
.  In the Abarracin study, 
rats were pre-treated for 180 sec at 60 mW/cm
2
 resulting in a dose of 10.8 J/cm
2
.  
150 
 
 
Comparing the efficacy of 830nm photobiomodulation using three different treatment 
paradigms- photobiomodulation during the critical period of photoreceptor degeneration 
(p10-p25), photobiomodulation during the onset of the critical period of photoreceptor cell 
death to young adulthood (p10-p 40) and photobiomodulation during the later stage (p20-p 
40) to rescue remaining photoreceptors was essential to characterize the most effective 
treatment window using 830 nm photons and with the current P23H transgenic model used 
in this study we report that the effective time period to perform 830nm PBM to attenuate 
disease progression is the ‘critical period’ of photoreceptor degeneration. Studies’ 
demonstrating the prolonged effect of brief photobiomodulation treatment implies 
interaction of NIR photons at the cellular level induces a cascade of events leading to the 
stimulation of gene expression, protein synthesis, and oxidative metabolism (Eells, Henry 
et al. 2003). The functional rescue of photoreceptors in p10-p 40 paradigm demonstrates 
the ability to use 830 nm photons from onset of the disease extending to adulthood. Future 
experiments will be designed to validate the efficacy of extended treatment protocols.  
Variability in the onset and presentation of clinical symptoms in RP with individuals 
having same mutation is challenging. The structural and functional preservation of 
photoreceptors in p20-p40 paradigm by 830nm photobiomodulation holds promise for the 
use of NIR PBM during the later stages of degeneration process. 
Oxidative stress associated with mitochondrial dysfunction play a key role in the 
pathogenesis of RP and in other retinal degenerative disorders including glaucoma, age 
related macular degeneration (AMD) and diabetic retinopathy (Kong, Tanito et al. 2007; 
Kong, Van Bergen et al. 2009; Karunadharma, Nordgaard et al. 2010). To the best of our 
knowledge, this thesis demonstrate the first attempts to provide a direct analysis of the 
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cellular metabolic state within the mitochondrial compartment of the retina of P23H 
transgenic rat model of RP by imaging endogenous fluorophores using novel optical 
cryofluorescence imaging technique that has very high sensitivity and specificity (Chapter 
5). NADH redox ratio, acts as a quantitative marker of the mitochondrial redox and 
metabolic state of tissue ex vivo and in vivo (Ranji, Jaggard et al. 2006; Ranji, Kanemoto et 
al. 2006; Sepehr, Staniszewski et al. 2012). Our findings showed that P23H transgene 
caused a significant increase in the oxidized forms (NAD and FAD) of the coenzymes 
NADH and FADH2 and NIR PBM by 830 nm reduced the NAD and FAD in the 
degenerating retina significantly there by altering the NADH redox ratio. The redox 
alterations observed in mitochondria results in the activation of intracellular signaling 
cascades which culminate in improved mitochondrial function, increased synthesis of 
cytoprotective factors and cell survival. We observed an increase in signal intensity in the 
eye samples from the vitreous in both NADH and FAD channels that needs to be further 
investigated and explained. 
Use of NIR PBM may be a challenge in individuals having inherited or induced retinal 
degeneration with anterior segment anomalies (e.g. primary defects in lens) of the eye 
which will interfere with the delivery of photons to the retina and it should be addressed 
while recruiting people in clinical trials. 
The functional, structural and metabolic insights obtained from the current study provides 
crucial information needed for clinical trials and FDA approval for the use of NIR-LED 
devices in the treatment of retinal degenerative diseases. By harnessing the potential of 
damaged cells to self-repair, photobiomodulation may provide an innovative and non-
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invasive therapeutic approach for the prevention and treatment of retinal degenerative 
disease. 
Future Directions 
Although photobiomodulation by NIR photons is extensively used by researchers to 
demonstrate preservation and stimulation of cellular events in various clinical and 
experimental animal models the use of photobiomodulation is still controversial and 
debated because of the incomplete knowledge of the mechanism of action and the 
differences in the treatment parameters used by various investigators like range of 
wavelength, dose, and the nature of light source- Laser vs. non-coherent light ; polarized 
vs. unpolarized; pulsed vs. continuous wave (Posten, Wrone et al. 2005; Quirk and Whelan 
2011; Wu, Xuan et al. 2012) (Chung, Dai et al. 2012). The altered kinetics of the 
photoacceptor molecule (cytochrome c oxidase) after NIR photon interaction and the how 
it alters the mitochondrial redox state that triggers secondary signaling cascades which 
culminate in improved mitochondrial function remains a ‘‘black box’’ and future 
experiments should emphasize to resolve the above issues. 
This thesis validated the safety of using NIR photobiomodulation in non-dystrophic rats in 
which animals are treated from p10-p25, which is the critical period of photoreceptor 
development, however, it is crucial to demonstrate that photobiomodulation does not 
adversely affect retinal function, metabolism and retinal architecture during prolonged 
treatment paradigms. So far there are no reported adverse effects of PBM in experimental 
and clinical studies (Whelan, Buchmann et al. 2003; Lampl, Zivin et al. 2007; Oron, Oron 
et al. 2012). Recent studies from our collaborators in alpha-synuclein transgenic mice 
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model of Parkinson’s disease showed no evidence of adverse effects in which animals 
were treated daily with 670 nm PBM for more than a year (Quirk, Desmet et al. 2012). 
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Purpose: Irradiation by light in the far-red to near-infrared (NIR) region of the spectrum 
(photobiomodualtion, PBM) has been demonstrated to attenuate the severity of 
neurodegenerative disease in experimental and clinical studies. The purpose of this study 
was to test the hypothesis that a brief course of 830 nm PBM would protect against the 
loss of retinal function and improve photoreceptor survival in a rodent model of retinitis 
pigmentosa. 
Methods: P23H-1 pups were treated once per day for 180 seconds with 830 nm light (25 
mW/cm
2
; fluence 4 J/cm
2
) using a light-emitting diode array (Quantum Devices, 
Barneveld WI) from postnatal day p10 to p25. Sham-treated rats were restrained for 180 
seconds, but not exposed to NIR light. The status of the retina was determined at p30 
by measuring indices of photoreceptor function by ERG (scotopic series from 
100mcd.s/m
2
 to 25000mcd.s/m
2
) and retinal morphology by Spectral Domain Optical 
Coherence Tomography (SD-OCT; line scans centered on the ONH, 
1000x80x1samplings; Bioptigen, Inc). Following SD-OCT analysis, animals were 
euthanized and the eyes harvested and prepared for histological and molecular analysis.   
Results: 830 nm PBM protected against retinal degeneration in the P23H rat as assessed 
by ERG and SD-OCT. In NIR treated animals the a-wave amplitude at 1000 mcd.s/m
2
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was 117 ± 10 µV compared to 77 ± 7 µV in sham treated animals (p=0.007).  The b-wave 
amplitude in NIR treated rats was 643 ± 49 µV compared to 415 ± 27 µV in sham treated 
animals (p=0.002).  Total retinal thickness measured by SD-OCT linear scans was 179 ± 
8 µm in NIR treated animals compared to 147± 8 µm for sham treated animals (p=0.04). 
Conclusions: Studies from our laboratory have documented preservation of retinal 
function and attenuation of photoreceptor loss by PBM in animal models of 
mitochondrial injury and light-induced retinal degeneration. Results from this study 
demonstrate the retinoprotective effects of 830nm PBM in a transgenic animal model of 
retinitis pigmentosa and support the use of PBM as an innovative, non-invasive 
therapeutic approach for the treatment of retinal degenerative disease.  
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670 nm Photobiomodulation Attenuates Light-Induced Retinal Degeneration 
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Purpose: Irradiation by light in the far-red to near-infrared (NIR) region of the spectrum 
(photobiomodulation; PBM) has been demonstrated to attenuate the severity of 
degenerative retinal diseases in experimental and clinical studies. The cytoprotective 
actions of NIR-PBM have been attributed to improved mitochondrial energy production 
and the up regulation of cytoprotective factors. The purpose of this study was to test the 
hypothesis that a brief course of 670 nm photobiomodulation would protect against the 
loss of retinal function, prevent mitochondrial dysfunction and attenuate photoreceptor 
loss in the light damaged retina. Methods: The eyes of adult female Sprague Dawley rats 
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(250 g) were treated with 670 nm light for 90 sec at 50 mW/cm2 (fluence = 4.5 
joules/cm2 ) using a light emitting diode array (Quantum Devices, Inc). Rats were treated 
once per day for 5 days prior to light damage [LD] (1500 lux for 24 h). Sham treated LD 
rats were restrained for 90 sec, but not exposed to 670 nm PBM. At day 7 following LD, 
retinal function was examined by ERG. At day 14, eyes were enucleated. One eye was 
prepared for histological evaluation and the retina from the other eye was removed, snap 
frozen and stored at -80 C for future analysis of mitochondrial function and antioxidant 
concentrations. Results: 670 nm photobiomodulation protected against LD-induced loss 
of rod and cone function. In sham-treated LD animals rod-mediated b-wave amplitude 
was 320 ± 78 mV compared to 450 ± 65 mV in NIR-treated LD rats. The rod-mediated 
b/a ratio was 14 ± 4 in sham-treated LD animals and 22 ± 6 in NIR-treated LD animals (p 
< 0.05). The cone-mediated b-wave in LD rats was 103 ± 9 mV compared to 165 ± 25 
mV (p < 0.05) in NIR-treated LD rats.Conclusions: Previous studies in our laboratory 
have demonstrated neuroprotective and retinoprotective actions of 670 nm PBM light 
treatment in vitro and in vivo. The present study extends these findings to include 
protection against light-damage induced photoreceptor dysfunction. Given the reliance of 
photoreceptors on mitochondrial oxidative metabolism and the evidence for LD-induced 
mitochondrial injury, we speculate that the observed retinoprotective actions of NIR 
PBM are due, in part, to the prevention of photoreceptor mitochondrial dysfunction and 
the induction of mitochondrial repair in retinal light damage. 
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